explaining “the Supreme Court has sought to discipline [the] application” of substantive due process lest “judges . . . usurp authority” that the Constitution entrusts to democracy (citation modified)
How later courts described this case
- explaining “the Supreme Court has sought to discipline [the] application” of substantive due process lest “judges . . . usurp authority” that the Constitution entrusts to democracy (citation modified)
- affirmatively stating in the concurrence that “transgender status is not a classification protected by the Equal Protection Clause.”
Written by the judges who cited it.
The opinion
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 1 of 173
In the
United States Court of Appeals
For the Eleventh Circuit
____________________
No. 22-11707
____________________
PAUL A. EKNES-TUCKER,
Rev.,
BRIANNA BOE,
individually and on behalf of her minor son, Michael Boe,
JAMES ZOE,
individually and on behalf of his minor son, Zachary Zoe,
MEGAN POE,
individually and on behalf of her minor daughter, Allison Poe,
KATHY NOE, et al.,
individually and on behalf of her minor son, Christopher Noe,
Plaintiffs-Appellees,
versus
GOVERNOR, OF THE STATE OF ALABAMA,
ATTORNEY GENERAL, STATE OF ALABAMA,
DISTRICT ATTORNEY, FOR MONTGOMERY COUNTY,
DISTRICT ATTORNEY, FOR CULLMAN COUNTY,
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 2 of 173
DISTRICT ATTORNEY, FOR LEE COUNTY, et al.,
Defendants-Appellants.
____________________
Appeal from the United States District Court
for the Middle District of Alabama
D.C. Docket No. 2:22-cv-00184-LCB-SRW
____________________
Before WILLIAM PRYOR, Chief Judge, WILSON, JORDAN,
ROSENBAUM, JILL PRYOR, NEWSOM, BRANCH, GRANT, LUCK, LAGOA,
and BRASHER, Circuit Judges. ∗
BY THE COURT:
A petition for rehearing having been filed and a mem-
ber of this Court in active service having requested a poll on
whether this case should be reheard by the Court sitting en
banc, and a majority of the judges in active service on this
Court having voted against granting rehearing en banc, it is
ORDERED that this case will not be reheard en banc.
∗ Judge Nancy Abudu recused herself and did not participate in the en banc
poll.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 3 of 173
WILLIAM PRYOR, Chief Judge, respecting the denial of rehearing en
banc:
I agree with the decision not to rehear this appeal en banc
and write only to respond to a dissenting opinion. Our respected
colleague argues that the “complex[]” doctrine of substantive due
process is “hard,” Jordan Dissent at 1, but the difficulty is inevitable.
The doctrine of substantive due process does violence to the text
of the Constitution, enjoys no historical pedigree, and offers judges
little more than shifting and unilluminating standards with which
to protect unenumerated rights. Unmoored from text and history,
the drift of the doctrine—“neither linear nor consistent,” id. at 20—
is predictable. So too is its patchy legacy: unelected judges with life
tenure enjoin enforcement of laws enacted by elected representa-
tives following regular procedures, all in the name of fundamental
rights that the Constitution never names but allegedly secures. In
the absence of clear guidance from the Supreme Court, we should
hesitate to expand the reach of this f lawed doctrine. And our Court
wisely declines to do so here.
As John Hart Ely famously put it, the phrase “substantive
due process” is a “contradiction in terms,” like “‘green pastel red-
ness.’” JOHN HART ELY, DEMOCRACY AND DISTRUST 18 (1980). The
Fifth and Fourteenth Amendments prohibit the federal and state
governments from depriving any person of life, liberty, or property
“without due process of law.” That constitutional guarantee is
about legal procedures, not the substance of laws. For that reason,
the Supreme Court has declared—unanimously—that the
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 4 of 173
“language” of the Due Process Clauses does not “suggest[],” let
alone support, the “substantive content” that courts often have
poured into them. Regents of the Univ. of Mich. v. Ewing, 474 U.S. 214,
225–26 (1985) (citation and internal quotation marks omitted). So,
the Due Process Clauses are a “most curious place” to ground all-
but-indefeasible protections for fundamental rights. McDonald v.
City of Chicago, 561 U.S. 742, 809 (2010) (Thomas, J., concurring in
part and in the judgment). Yet the doctrine of substantive due pro-
cess shields individuals from even “general and prospective legisla-
tion enforced with all proper procedure.” Nathan S. Chapman &
Michael W. McConnell, Due Process as Separation of Powers, 121
YALE L.J. 1672, 1792 (2012).
In addition to incorporating against the States most of the
protections that the Bill of Rights guarantees against the federal
government, the doctrine bars state infringement of “fundamental
rights that are not mentioned anywhere in the Constitution.” Dobbs
v. Jackson Women’s Health Org., 142 S. Ct. 2228, 2246 (2022). That bar
is not absolute, at least in theory; a challenged law may deprive an
individual of a fundamental right if it satisfies strict scrutiny. See
Waldman v. Conway, 871 F.3d 1283, 1292 (11th Cir. 2017). But strict
scrutiny does not pertain to either the form of adjudication that
must accompany the deprivation or the procedures that the adju-
dication must observe—that is, to process. See Ryan C. Williams, The
One and Only Substantive Due Process Clause, 120 YALE L.J. 408, 419
(2010). The condition rests instead on the importance of the goal
of the law and the narrowness of its means—that is, on nonproce-
dural grounds. See Waldman, 871 F.3d at 1292. And even when no
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 5 of 173
fundamental interest is at stake, the doctrine bars any “arbitrary
and oppressive exercise of government power” and all government
conduct that “shocks the conscience.” Id. (citation and internal
quotation marks omitted).
The doctrine of substantive due process has “long been con-
troversial,” Dobbs, 142 S. Ct. at 2246, because its potent strictures
on democratic self-governance have “no footing in constitutional
text” or history. Sosa v. Martin County, 57 F.4th 1297, 1305–06 (11th
Cir. 2023) (en banc) (Newsom, J., concurring). Under the “tradi-
tional view,” the Founders would have understood the Due Process
Clause of the Fifth Amendment either not to “constrain the legis-
lature at all” or to “limit the legislature’s discretion in prescribing
certain modes of judicial procedure.” Williams, supra, at 454. That
traditional view remains dominant. See, e.g., MICHAEL STOKES
PAULSEN & LUKE PAULSEN, THE CONSTITUTION 216 (2015) (due pro-
cess required “executive branch and judicial officials [to] act in ac-
cordance with the legal rules—laws—that ha[d] been made in ad-
vance of the events at hand”); Chapman & McConnell, supra, at
1679; Timothy M. Tymkovich, Joshua Dos Santos & Joshua J.
Craddock, A Workable Substantive Due Process, 95 NOTRE DAME L.
REV. 1961, 1966–67 (2020). Disagreement on the edges of the scope
of the right should not obscure the bottom line: substantive due
process is an ahistorical “legal fiction.” McDonald, 561 U.S. at 811
(Thomas, J., concurring in part and in the judgment). And nothing
relevant had changed by 1868. Even then, there was almost no his-
torical support for the policy-second-guessing function that the
doctrine performs today. See Chapman & McConnell, supra, at
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 6 of 173
1679–80, 1801, 1807; Williams, supra, at 499; Tymkovich et al., su-
pra, at 1972–73.
Some scholars argue that the phrase “due process of law”
was a “legal term of art with substantive content” when the Four-
teenth Amendment was ratified in 1868. See, e.g., Williams, supra,
at 496 (presenting the argument). But that argument is “hardly air-
tight,” id., and “[n]o evidence” establishes that the word “process”
“meant something different” in 1868, set aside 1791, from what it
does now, see ELY, supra, at 18. To trained observers no less than the
ordinary man, the choice of the phrase “due process of law” to af-
ford constitutional protection to substantive rights would have
seemed “very odd.” Chapman & McConnell, supra, at 1725.
A constitutional doctrine that lacks foundation in text or his-
tory must draw its content from another source, and substantive
due process has offered judges little more than “scarce and open-
ended” platitudes. Collins v. City of Harker Heights, 503 U.S. 115, 125
(1992). The doctrine has been said to protect rights that comprise
the “essence of a scheme of ordered liberty,” McDonald, 561 U.S. at
760 (plurality opinion) (citation and internal quotation marks omit-
ted), or to bar state action that “shocks the conscience,” Waldman,
871 F.3d at 1292 (citation and internal quotation marks omitted).
These “vague shibboleths” clarify little. Sierra v. City of Hallandale
Beach, 996 F.3d 1110, 1128 (11th Cir. 2021) (Newsom, J., concur-
ring). That feature of substantive due process sits dangerously
alongside the power that the doctrine gives life-tenured judges: to
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 7 of 173
declare unconstitutional, and enjoin enforcement of, duly enacted
laws of elected representatives of the People.
Unconstrained power tempts usurpation. The history of
substantive due process bears out that plain truth. In many deci-
sions, the Supreme Court has stated that the approach to constitu-
tional decision-making typified by Lochner v. New York, 198 U.S. 45
(1905), was “illegitimate,” an “intrusion by the courts into a realm
properly reserved to the political branches of government.” Cass
R. Sunstein, Lochner’s Legacy, 87 COLUM. L. REV. 873, 874 (1987).
The “freewheeling judicial policymaking” that marked “discred-
ited” decisions like Lochner and Roe v. Wade, 410 U.S. 113 (1973), see
Dobbs, 142 S. Ct. at 2248, is a feature, not a bug, of substantive due
process. And it discredits the judiciary itself. See, e.g., Dred Scott v.
Sandford, 60 U.S. (19 How.) 393 (1857).
Because the doctrine can empower judges to “usurp” au-
thority that the Constitution leaves to elected representatives, see
Dobbs, 142 S. Ct. at 2247, the Supreme Court has sought to disci-
pline its application. The Court has stated, for example, that a right
or liberty must be “deeply rooted” in our “history and tradition” to
be immune from legislative encroachment. Washington v. Glucks-
berg, 521 U.S. 702, 720–21 (1997) (citation and internal quotation
marks omitted). In this analysis, “liberty” must be defined “in a
most circumscribed manner,” in reference to “specific historical
practices.” Obergefell v. Hodges, 576 U.S. 644, 671 (2015). That is, the
asserted right must be “careful[ly] descri[bed].” Reno v. Flores, 507
U.S. 292, 302 (1993).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 8 of 173
Sometimes courts have defined the asserted unenumerated
right at a specific level. In Reno, for example, the Supreme Court
rejected the proposed general description of the right at issue—
“freedom from physical restraint”—and defined the right instead
more specifically as the “right of a child who has no available par-
ent, close relative, or legal guardian, and for whom the government
is responsible, to be placed in the custody of a willing-and-able pri-
vate custodian rather than of a government-operated or govern-
ment-selected child-care institution.” Id. (quotation marks omit-
ted). And in Doe v. Moore, we rejected a “broad framing” of the
rights at issue—including the rights “to family association” and to
“be free of threats to their persons and members of their immedi-
ate families”—for a more “careful” description: the “right of a per-
son, convicted of ‘sexual offenses,’ to refuse subsequent registra-
tion of his or her personal information with Florida law enforce-
ment and [to] prevent publication of this information on Florida’s
Sexual Offender/Predator website.” 410 F.3d 1337, 1343–44 (11th
Cir. 2005).
To be sure, the Glucksberg test has proved occasional. In Law-
rence v. Texas, the Supreme Court endorsed the uncircumscribed
view that the Due Process Clause protected a “liberty of the person
both in its spatial and in its more transcendent dimensions.” 539
U.S. 558, 562 (2003). And in Obergefell, the Court set aside the Glucks-
berg test and defined the right to marry in a more “comprehensive
sense.” 576 U.S. at 671.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 9 of 173
Yet what judicial creativity gives, a measure of judicial re-
straint can take away. For example, Dobbs did not mention the al-
ternative Obergefell method. So I agree with our dissenting col-
league that binding precedents like these are “not . . . reconcilable”
on the key question of how narrowly to define the liberty interest.
Jordan Dissent at 20.
This inconsistency is unsurprising. It is inevitable. The “con-
troversial nature” of the doctrine of substantive due process—its
lack of footing in text or history and the absence of consistent and
meaningful legal standards to guide judicial analysis—make the
caselaw “contradictory” and “imprecise.” Tymkovich et al., supra,
at 1963.
With good reason, the Supreme Court has long counseled
“reluctan[ce] to expand the concept of substantive due process.”
Collins, 503 U.S. at 125. Judicial restraint, with its respect for the sep-
aration of powers and for federalism, demands “utmost care” be-
fore courts interfere. See id. We must “guard against the natural hu-
man tendency” to conf late what due process requires with “our
own ardent views about the liberty that Americans should enjoy.”
Dobbs, 142 S. Ct. at 2247. And we must remember that the amor-
phous doctrine of substantive due process does not shield every
“important, intimate, and personal decision[]” from legislative im-
pairment. Glucksberg, 521 U.S. at 727. So, when we consult “juris-
prudence as a whole” to glean guidance, Jordan Dissent at 20, we
should be skeptical about any argument to extend this misguided
doctrine, with its checkered past, to define an unenumerated right
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 10 of 173
at a high level of generality and enjoin enforcement of a law en-
acted by representatives of the People. Difficult questions of mo-
rality, parental rights, and medicine are properly left to democracy,
and we should not pretend that the Due Process Clauses give une-
lected judges the authority to second-guess public policy.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 11 of 173
LAGOA, Circuit Judge, Concurring in the denial of rehearing en
banc:
Sydney Wright took large doses of cross-sex hormones for a
year. In Wright’s words, her grandfather “saved [her] life” when
he persuaded her to stop. As a teenager, Wright’s father kicked her
out of the house after he learned that she was attracted to women,
and Wright began questioning if she “was really a man” because
she “was attracted to girls.” Wright saw a counselor who recom-
mended that she begin taking testosterone and undergo a double
mastectomy. The counselor never explored the negative effects of
Wright’s relationship with her parents or the years of sexual mo-
lestation that she endured as a child. Wright started testosterone
injections after a ten-minute appointment with a physician who
told her to learn “on YouTube” how to “give [herself] the shots.”
Testosterone caused Wright’s voice to deepen, perma-
nently. She also gained fifty pounds and became pre-diabetic. After
a year, her blood thickened, her red-blood-cell count increased, and
she developed a blood disorder that could lead to heart attack and
stroke. She also began experiencing excruciating abdominal pain,
which she continues to suffer from. One day, her grandfather—
who Wright describes as “the most important man in [her] life”—
had a “down-to-earth” talk with her. With “tears in his eyes,” he
expressed concern about her treatment and asked her to take a
three-year break to reevaluate her decision. According to Wright,
her grandfather was “worried about [her] health,” and he “never
cared how [she] looked.” Wright agreed to take a break, and on
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 12 of 173
further reflection, realized that she needed counseling, not hor-
mone medications. Wright still suffers negative side effects from
cross-sex hormones, including digestive problems, tachycardia,
and an increased red-blood-cell count. Her gynecologist also told
her that she may never be able to have children.
The record contains many stories of others who were irre-
versibly harmed by similar medications. 1 The Alabama Legislature
decided to respond through Alabama’s Vulnerable Child Compas-
sion and Protection (“Act”). In relevant part, section 4(a)(1)–(3) of
the Act provides that “no person shall” prescribe or administer pu-
berty blocking medication or cross-sex hormones to a minor “for
the purpose of attempting to alter the appearance of or affirm the
minor’s perception of his or her gender or sex, if that appearance
or perception is inconsistent with the minor’s sex.” A federal dis-
trict court preliminarily enjoined enforcement of part of the Act
under the Due Process Clause and the Equal Protection Clause of
the Fourteenth Amendment. But we reversed. Now, a majority
of the active judges on this Court have correctly determined not to
1 See, e.g., Appendix A (KathyGrace Duncan), Appendix B (Carol Frietas), Ap-
pendix C (Corinna Cohn). One of the dissents argues that we should disregard
Wright’s testimony and the testimonies of Duncan, Frietas, and Cohn because
all of them were at least eighteen years old when they started to medically
transition and because “their ‘treatment’ did not follow WPATH Standards of
Care.” Rosenbaum Dis. Op. at 10–11, 10 n.8. But that is not a reason to dis-
regard their testimony, which demonstrates that those who are eighteen or
older may fail to understand the dangerous, long-term effects cross-sex hor-
mones and puberty blockers can have. If anything, these testimonies show
why a legislative body may choose to restrict the use of these drugs by minors.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 13 of 173
rehear this case en banc. The Act, “like other health and welfare
laws, is entitled to a ‘strong presumption of validity.’” Dobbs v. Jack-
son Women’s Health Org., 597 U.S. 215, 301 (2022) (quoting Heller v.
Doe ex rel. Doe, 509 U.S. 312, 319 (1993)).
Judge Rosenbaum’s dissent characterizes the panel opinion
as holding that parents do not have a constitutional right to access
“life-saving medical care” for their children. Rosenbaum Dis. Op.
at 4; see also Jordan Dis. Op. at 22 (describing the asserted right as
“the right of parents to obtain medically-approved treatment for
their children”). But frankly, whether puberty blockers and cross-
sex hormones qualify as “life-saving” treatment—or even “medical
care”—is a policy question informed by scientific, philosophical,
and moral considerations. Neither an unelected district judge nor
unelected circuit judges should resolve that debate for the State of
Alabama. See Kadel v. Folwell, 100 F.4th 122, 196 (4th Cir. 2024) (en
banc) (Wilkinson, J., dissenting) (“Self-governance is notably ab-
sent when the many voices seeking to provide answers are silenced
by federal judges shrouded in an authority of their own design.”).
Indeed, “when a legislature ‘undertakes to act in areas
fraught with medical and scientific uncertainties, legislative options
must be especially broad and courts should be cautious not to re-
write legislation.’” Kansas v. Hendricks, 521 U.S. 346, 360 n.3 (1997)
(quoting Jones v. United States, 463 U.S. 354, 370 (1983)). And this
case only serves to underscore why. While we must evaluate the
district court’s work on the record it had in front of it at the time,
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 14 of 173
recent revelations confirm the danger that comes from hastening
to afford constitutional protection in this area.
For example, in April 2024, Dr. Hillary Cass—the chair of a
policy group commissioned by England’s National Health Service
(“NHS”)—published the results of her four-year review of the use
of puberty blockers and cross-sex hormones on minors. 2 Cass
found no evidence that puberty blockers improve gender dyspho-
ria and no evidence that cross-sex hormones reduce suicide risk for
children suffering from gender dysphoria. See The Cass Review,
supra n.2, at 179, 186, 195. Cass also documented the extensive
risks associated with puberty blockers. See, e.g., id. at 177–78. In
conjunction with the Cass Review, NHS announced “that there is
not enough evidence to support the safety or clinical effectiveness
of [puberty suppressing hormones] to make the treatment rou-
tinely available at this time.” 3 And, on May 29, 2024, the United
Kingdom’s Secretary of State for Health and Social Care and North-
ern Ireland’s Minister for Health issued a temporary emergency or-
der that “prohibits”—with limited exceptions—puberty blockers
2 The Cass Review, Independent review of gender identity services for children and
young people (2024), https://cass.independent-review.uk/wp-content/up-
loads/2024/04/CassReview_Final.pdf [https://perma.cc/9F73-D7BW]
(hereinafter, “The Cass Review”).
3 Clinical Policy: Puberty suppressing hormones (PSH) for children and young people
who have gender incongruence/gender dypsphoria [1927], Nat’l Health Serv., Eng.
(Mar. 12, 2024), https://www.england.nhs.uk/wp-content/up-
loads/2024/03/clinical-commissioning-policy-gender-affirming-hormones-
v2.pdf [https://perma.cc/383H-LBVX] (hereinafter, “NHS Clinical Policy”).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 15 of 173
for people under the age of 18. See TransActual CIC v. Sec’y of State
for Health and Social Care [2024] EWHC 1936 (Admin), ¶¶ 2, 142–48.
On July 29, 2024, the UK’s High Court dismissed a legal challenge
to the emergency order, citing the Cass Review as “powerful scien-
tific evidence in support of restrictions on the supply of puberty
blockers on the grounds that they were potentially harmful.” See
id. ¶¶ 210, 257.
Also, in March 2024, a whistleblower leaked documents and
recordings impugning the credibility of the World Professional As-
sociation for Transgender Health (WPATH), 4 which promulgates
the “Standards of Care” that the district court relied on in its order.
Eknes-Tucker v. Marshall (“Eknes-Tucker I”), 603 F. Supp. 3d 1131,
1138–39 (M.D. Ala. 2022). The leaked documents suggest that
WPATH officials are aware of the risks of cross-sex hormones and
other procedures yet are mischaracterizing and ignoring infor-
mation about those risks. See, e.g., infra at 47–49. Again, I highlight
these developments only to demonstrate the ill-suitedness of this
area for judicial intervention.
The propriety of the medications at issue is a quintessential
legislative question, not a constitutional one. Judges Jordan and
Rosenbaum would have this Court end the debate by judicially
fencing off these questions from state legislatures. But our
4 Mia Hughes, The WPATH Files, Environmental Progress (2024),
https://static1.squarespace.com/static/56a45d683b0be33df885def6/t/65ea1
c1ea42ff5250c88a2f5/1709841455308/WPATH+Report+and+Files%28N%2
9.pdf [https://perma.cc/5HLY-TSUR] (hereinafter, “The WPATH Files”).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 16 of 173
experience with the intersection of the Constitution and these
types of issues suggests that this is a misguided effort. See Roe v.
Wade, 410 U.S. 113 (1973), overruled by Dobbs, 597 U.S. at 302 (“re-
turn[ing]” “authority to the people and their elected representa-
tives” to regulate abortion). Compare Buck v. Bell, 274 U.S. 200
(1927), with Box v. Planned Parenthood Ind. & Ky., Inc., 587 U.S. 490,
499–500 (2019) (Thomas, J., concurring) (noting that Buck v. Bell
“gave the eugenics movement added legitimacy and considerable
momentum”). Our panel opinion correctly declined to remove
these issues from the political process by rejecting a novel reading
of the Fourteenth Amendment that is unmoored from text, history,
and tradition.
I. FACTUAL BACKGROUND AND PROCEDURAL
HISTORY
The panel opinion provides a thorough summary of the fac-
tual background and procedural history. See Eknes-Tucker v. Gover-
nor of Alabama (“Eknes-Tucker II”), 80 F.4th 1205, 1211–19 (11th Cir.
2023). Here, I provide a summary of the relevant provisions of the
Act and a brief overview of the procedural history.
A. The Act
The Alabama Legislature passed the Act on April 7, 2022,
and Governor Ivey signed it the next day. Section 3(1) incorporates
the definition of “minor” found in another part of the code, which
is a “person who is under 19 years of age.” Ala. Code § 43-8-1(18).
And section 3(3) defines “sex” to mean “[t]he biological state of be-
ing male or female, based on the individual’s sex organs,
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 17 of 173
chromosomes, and endogenous hormone profiles.” Section 4(a)
then states, in part, that “no person shall engage in or cause” the
prescription or administration of (1) “puberty blocking medication
to stop or delay normal puberty,” (2) “supraphysiologic 5 doses of
testosterone or other androgens to females,” or (3) “supraphysio-
logic doses of estrogen to males,” “for the purpose of attempting
to alter the appearance of or affirm the minor’s perception of his or
her gender or sex, if that appearance or perception is inconsistent
with the minor’s sex.” 6 Section 4(b), however, provides an excep-
tion if “a procedure [is] undertaken to treat a minor born with a
medically verifiable disorder of sex development,” and includes
some examples of such disorders. 7
5 Supraphysiologic means of or pertaining to an amount “greater than nor-
mally present in the body.” See Supraphysiologic, Merriam-Webster,
https://www.merriam-webster.com/medical/supraphysiological
[https://perma.cc/QW8K-882J].
6 Section 4 also forbids performing surgeries that sterilize, performing surger-
ies that “artificially construct tissue with the appearance of genitalia that differs
from the individual’s sex,” and removing “any healthy or non-diseased body
part or tissue, except for a male circumcision.” Act § 4(a)(4)–(6). Plaintiffs
originally challenged these portions of the Act also, but represented at the be-
ginning of the preliminary-injunction hearing below that they were no longer
seeking a preliminary injunction with respect to them. See Eknes-Tucker I, 603
F. Supp. 3d at 1139 n.5.
7 These disorders include: (1)“[a]n individual born with external biological sex
characteristics that are irresolvably ambiguous, including an individual born
with 46 XX chromosomes with virilization, 46 XY chromosomes with under
virilization, or having both ovarian and testicular tissue”; and (2) “[a]n individ-
ual whom a physician has otherwise diagnosed with a disorder of sexual de-
velopment, in which the physician has determined through genetic or
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 18 of 173
B. Procedural History
Shortly after the Governor signed the Act, the Plaintiffs—
including transgender minors (the “Minor Plaintiffs”) and their par-
ents (the “Parent Plaintiffs”)—sued several Alabama state officials
(collectively, “Alabama”). Relevant to this appeal, the Plaintiffs al-
leged that the Act violated the Due Process Clause of the Four-
teenth Amendment by depriving the Parent Plaintiffs of their right
to direct the upbringing of their children, and alleged that the Act
violated the Equal Protection Clause by discriminating against the
Minor Plaintiffs on account of their sex and transgender status.
The Plaintiffs then moved for a preliminary injunction. 8 Af-
ter a three-day hearing—at which the district court heard evidence
from both sides about the efficacy of the treatments proscribed by
the Act, see Eknes-Tucker II, 80 F.4th at 1215–18—the district court
granted the Plaintiffs’ motion with respect to Section 4(a)(1)–(3),
see Eknes-Tucker I, 603 F. Supp. 3d at 1138, 1151. The district court
concluded that the Plaintiffs had a substantial likelihood of success
on the merits as to their due-process and equal-protection claims.
With respect to the due-process claim, the district court concluded
biochemical testing that the person does not have normal sex chromosome
structure, sex steroid hormone production, or sex steroid hormone action for
a male or female.” Act § 4(b).
8 The United States moved to intervene on behalf of the Plaintiffs under Fed-
eral Rule of Civil Procedure 24 and filed its own motion to enjoin enforcement
of the Act on equal-protection grounds. The district court granted interven-
tion and the United States’s motion for injunctive relief to the same extent it
granted the Plaintiffs’ motion. Eknes-Tucker I, 603 F. Supp. 3d at 1151.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 19 of 173
that the Parent Plaintiffs were substantially likely to show that they
have a “fundamental right to treat their children with transitioning
medications subject to medically accepted standards,” and that sec-
tion 4(a)(1)–(3) violates this right, triggering strict scrutiny. Id. at
1144–45. And, in the eyes of the district court, section 4(a)(1)–(3)
likely failed to satisfy strict scrutiny. Id. at 1146. With respect to
the equal-protection claim, the district court concluded that the Act
“amounts to a sex-based classification,” meaning it needed to sat-
isfy intermediate scrutiny. Id. at 1147. Again, the district court
found that the Act likely failed to meet this burden. Id. at 1148.
Alabama subsequently appealed.
II. ANALYSIS
On appeal, the panel unanimously concluded that the dis-
trict court abused its discretion by preliminarily enjoining Alabama
officials from enforcing section 4(a)(1)–(3) of the Act. Eknes-Tucker
II, 80 F.4th at 1210. We held that the Due Process Clause does not
secure “a constitutional right to ‘treat [one’s] children with transi-
tioning medications subject to medically accepted standards,’” and
that the Act does not discriminate “on the basis of sex or any other
protected characteristic.” Id. at 1210–11, 1219–31 (alteration in the
original). Thus, we concluded that section 4(a)(1)–(3) was subject
only to rational-basis review, and, as a consequence, the district
court’s “determination that the plaintiffs have established a sub-
stantial likelihood of success on the merits [could not] stand.” Id.
at 1210–11; see id. at 1231. We therefore vacated the preliminary
injunction. Id. at 1211, 1231.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 20 of 173
Some of my dissenting colleagues interpret the Fourteenth
Amendment differently. I respectfully disagree. Below, I first ex-
plain why the panel’s understanding of the Fourteenth Amend-
ment is consistent with text, history, tradition, and existing prece-
dent. I then explain why Alabama’s decision is a rational exercise
of its police power.
A. Substantive Due Process
The Due Process Clause of the Fourteenth Amendment pro-
vides that no State shall “deprive any person of life, liberty, or prop-
erty, without due process of law.” U.S. Const. amend. XIV, § 1.
Because this Clause makes no express mention of a parent’s right
to access cross-sex hormones and puberty blockers on behalf of a
child, the Parent Plaintiffs “must show that the right is somehow
implicit in the constitutional text.” Dobbs, 597 U.S. at 235.
“The most familiar office of [the Due Process] Clause is to
provide a guarantee of fair procedure in connection with any dep-
rivation of life, liberty, or property by a State.” Collins v. City of
Harker Heights, 503 U.S. 115, 125 (1992). But the Supreme Court
has said that the Due Process Clause protects “two categories of
substantive rights”—a great majority of those enumerated in the
first eight Amendments as well as “a select list of fundamental
rights that are not mentioned anywhere in the Constitution.”
Dobbs, 597 U.S. at 237. The Supreme Court has long been “reluc-
tant” to add a new right to this list, Collins, 503 U.S. at 125, because
“[i]dentifying unenumerated rights carries a serious risk of judicial
overreach,” Dep’t of State v. Muñoz, 144 S. Ct. 1812, 1821–22 (2024);
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 21 of 173
cf. United States v. Johnson, 921 F.3d 991, 1021 (11th Cir. 2019) (en
banc) (Rosenbaum, J., dissenting) (recognizing that “the ‘doctrine
of judicial self-restraint requires us to exercise the utmost care
whenever we . . . break new ground’” (alteration in the original)
(quoting Collins, 503 U.S. at 125)). Otherwise, “the liberty pro-
tected by the Due Process Clause” would simply reflect the “policy
preferences” of the federal judiciary. Washington v. Glucksberg, 521
U.S. 702, 720 (1997).
Out of this cautious approach grew the requirement that a
substantive-due-process analysis “must begin with a careful de-
scription of the asserted right.” Reno v. Flores, 507 U.S. 292, 302
(1993). Heeding this directive, the panel opinion’s description of
the right claimed here came directly from the district court, which
concluded that the Parent Plaintiffs likely have a “fundamental
right to treat their children with transitioning medications subject
to medically accepted standards.” Eknes-Tucker I, 603 F. Supp. 3d at
1144.
The dissents take issue with this framing. Judge Jordan de-
scribes our analysis as “too simple” and says that we “ignore[] many
Supreme Court cases that define fundamental rights at a much
more general level without requiring established and precise his-
torical pedigrees.” Jordan Dis. Op. at 2. He “cite[s] with confidence
to the dissent of Justice Stevens in McDonald,” id. at 7, where Justice
Stevens suggested that courts need not “define the asserted right at
the most specific level, thereby sapping it of a universal valence and
moral force it might otherwise have,” McDonald v. City of Chicago,
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 22 of 173
561 U.S. 742, 882 (2010) (Stevens, J., dissenting). Judge Jordan
would instead define the right as a parent’s right “to obtain medi-
cally-approved treatment for their children.” Jordan Dis. Op. at 22.
Judge Rosenbaum defines the right at stake as “parents’ fun-
damental right to direct that their child receive well-established,
evidence-based, non-experimental medical treatment, subject to
medically accepted standards and a physician’s independent exam-
ination and medical judgment.” Rosenbaum Dis. Op. at 1. Her
opinion also faults our panel for “hyper-narrowly describ[ing] the
asserted right.” Id. at 31.
And Judge Wilson argues that en banc review is justified be-
cause of Judges Jordan and Rosenbaum’s disagreement with our
framing of the supposed right at stake, as well as the fact that the
district court also framed the right at a higher level of generality.
Wilson Dis. Op. at 1–2.
Respectfully, the panel’s framing of the right is squarely
within the approach taken by our Circuit, as Judge Jordan acknowl-
edges. See Jordan Dis. Op. at 1 (recognizing that “[t]here is admit-
tedly some support in our cases for the panel’s approach”). For
example, in Doe v. Moore, 410 F.3d 1337 (11th Cir. 2005), the plain-
tiffs challenged, among other things, Florida’s sex offender registra-
tion/notification scheme. Id. at 1339. The plaintiffs argued that
this scheme—under which sex offenders registered and then the
state published their information on the internet—violated sub-
stantive due process. Id. at 1342. Specifically, the plaintiffs alleged
that it infringed their “rights to family association, to be free of
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 23 of 173
threats to their persons and members of their immediate families,
to be free of interference with their religious practices, to find
and/or keep any housing, and . . . to find and/or keep any employ-
ment.” Id. at 1343.
But instead of accepting this broad framing of the supposed
rights at stake, this Court “endeavor[ed] to create a more careful
description of the asserted right in order to analyze its importance.”
Id. A “careful description of the fundamental interest at issue here,”
we explained, “allows us to narrowly frame the specific facts before
us so that we do not stray into broader ‘constitutional vistas than
are called for by the facts of the case at hand.’” Id. at 1344 (quoting
Williams v. Att’y Gen. of Ala., 378 F.3d 1232, 1240 (11th Cir. 2004)).
This did not mean, we said, that “cases involving other privacy in-
terests or burdens on those interests” were irrelevant, only that
“we must quantify the claimed right in narrow terms before ana-
lyzing its historical importance in the second prong where discus-
sion of prior case law is more appropriate.” Id. at 1344 n.4. So,
after reviewing the law and the parties’ arguments, we determined
that that supposed right at issue there was “the right of a person,
convicted of ‘sexual offenses,’ to refuse subsequent registration of
his or her personal information with Florida law enforcement and
prevent publication of this information on Florida’s Sexual Of-
fender/Predator website.” Id. at 1344.
Similarly, in Morrissey v. United States, 871 F.3d 1260 (11th
Cir. 2017), the plaintiff alleged that the IRS’s disallowance of a
claimed deduction for IVF-related costs infringed “his fundamental
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 24 of 173
right to reproduce.” Id. at 1268. We recognized that the Supreme
Court had “referred to procreation as ‘fundamental to the very ex-
istence and survival of the [human] race’ and as a ‘basic civil right[]
of man.’” Id. (alterations in the original) (quoting Skinner v. Okla-
homa, 316 U.S. 535, 541 (1942)). But the question in Morrissey, we
said, was “not whether the Constitution protects a right to ‘procre-
ation’ generally.” Id. at 1269. Rather than rest at this level of gen-
erality, this Court went further, providing that the pertinent ques-
tion in the case was “whether a man has a fundamental right to
procreate via an IVF process that necessarily entails the participa-
tion of an unrelated third-party egg donor and a gestational surro-
gate.” Id.
The approach taken by these cases explains our framing of
the alleged “right” at issue here. 9 And while it is true that a plurality
of the Supreme Court has recognized, at a high level of generality,
“the fundamental right of parents to make decisions concerning the
care, custody, and control of their children,” Troxel v. Granville, 530
U.S. 57, 66 (2000) (plurality opinion), there is no accompanying sug-
gestion from the Court that plaintiffs asserting a supposed right un-
der this umbrella are exempt from the “careful description” re-
quirement found elsewhere in the case law. To the contrary, as a
recent decision makes clear, the Court has continued to define
9 As I discuss below, even if we were to accept the framing offered by either
Judge Jordan or Judge Rosenbaum, both still fail to “engage[] in a careful anal-
ysis of the history of the right at issue.” Dobbs, 597 U.S. at 238.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 25 of 173
alleged unenumerated rights narrowly so as to maintain fidelity to
the facts before it in each case. See Muñoz, 144 S. Ct. at 1822. 10
There is also the fact that most of the cases concerning pa-
rental rights “pertain to issues of education, religion, or custody.”
Eknes-Tucker II, 80 F.4th at 1222. In Meyer v. Nebraska, 262 U.S. 390
(1923), the Supreme Court set aside a schoolteacher’s conviction,
which was predicated on the violation of a state law forbidding the
teaching of most foreign languages before the eighth grade. Id. at
396–97, 401–403. Among other things, the Court reasoned that the
“liberty” guaranteed by the Due Process Clause included the right
to “establish a home and bring up children.” Id. at 399. Two years
later, in Pierce v. Society of the Sisters of the Holy Names of Jesus & Mary,
268 U.S. 510 (1925), the Supreme Court concluded that an Oregon
law—which required children from ages eight to sixteen to attend
public school—“unreasonably interfere[d] with the liberty of par-
ents and guardians to direct the upbringing and education of chil-
dren under their control.” Id. at 530, 534–35; see also id. at 535 (“The
child is not the mere creature of the state; those who nurture him
and direct his destiny have the right, coupled with the high duty,
to recognize and prepare him for additional obligations.”).
Child labor laws were at issue in Prince v. Massachusetts, 321
U.S. 158 (1944). The petitioner, a Jehovah’s Witness, was the aunt
10 In Muñoz, the respondent invoked the “fundamental right of marriage,” but
the Court pushed further, concluding that the respondent actually “claim[ed]
something distinct: the right to reside with her noncitizen spouse in the United
States.” 144 S. Ct. at 1822 (emphasis omitted).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 26 of 173
and custodian of a nine-year-old girl. Id. at 159, 161. After allowing
the girl to assist with sidewalk preaching efforts, the petitioner was
charged with furnishing the girl with magazines to sell and permit-
ting her to work in violation of the law. Id. at 160, 162. Pointing
to Meyer and Pierce, the Court said that it “is cardinal with us that
the custody, care and nurture of the child reside first in the parents,
whose primary function and freedom include preparation for obli-
gations the state can neither supply nor hinder.” Id. at 166. At the
same time, the Court recognized “that the state has a wide range
of power for limiting parental freedom and authority in things af-
fecting the child’s welfare” and that the “state’s authority over chil-
dren’s activities is broader than over like actions of adults.” Id. at
167–68.
In Wisconsin v. Yoder, 406 U.S. 205 (1972), the Supreme Court
held that Wisconsin’s compulsory-school attendance law for stu-
dents up to the age of sixteen violated the First and Fourteenth
Amendments. Id. at 234. The Court described the interest at stake
as “the fundamental interest of parents . . . to guide the religious
future and education of their children.” Id. at 232; see id. at 233
(“[T]he Court’s holding in Pierce stands as a charter of the rights of
parents to direct the religious upbringing of their children.”). But
even in Yoder, the Court made clear that “the power of the parent,
even when linked to a free exercise claim, may be subject to limi-
tation under Prince if it appears that parental decisions will jeopard-
ize the health or safety of the child, or have a potential for signifi-
cant social burdens.” Id. at 233–34.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 27 of 173
The Supreme Court’s other parental-rights cases mostly in-
volve custody issues. Stanley v. Illinois, 405 U.S. 645 (1972), for ex-
ample, concerned an unwed father’s challenge to Illinois’s proce-
dure for custody determinations upon the death of the mother. Id.
at 646–47. The Court held that the procedure—which presumed
unwed fathers are unfit to raise their children—was at odds with
the Fourteenth Amendment. Id. at 657–58. Along the way, the
Court recognized that the father’s interest in “retaining custody of
his children is cognizable and substantial” and that a parent’s inter-
est “in the companionship, care, custody, and management of his
or her children ‘come[s] to this Court with a momentum for re-
spect lacking when appeal is made to liberties which derive merely
from shifting economic arrangements.’” Id. at 651–52 (alteration
in the original) (quoting Kovacs v. Cooper, 336 U.S. 77, 95 (1949)
(Frankfurter, J., concurring)). At issue in Quilloin v. Walcott, 434
U.S. 246 (1978), was the constitutionality of the application of
Georgia’s adoption law “to deny an unwed father authority to pre-
vent adoption of his illegitimate child.” Id. at 247. While the Court
recognized that “the relationship between parent and child is con-
stitutionally protected” and said that “it is now firmly established
that ‘freedom of personal choice in matters of . . . family life is one
of the liberties protected by the Due Process Clause of the Four-
teenth Amendment,’” it concluded that Georgia’s law was not un-
constitutional as applied. Id. at 255 (alteration in the original)
(quoting Cleveland Bd. of Educ. v. LaFleur, 414 U.S. 632, 639–640
(1974)).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 28 of 173
In Santosky v. Kramer, 455 U.S. 745 (1982), the Supreme
Court considered the constitutionality of New York’s statutory
scheme governing the termination of parental rights in cases of per-
manent neglect. Id. at 748–52. The Court held that the parents in
that case were deprived of due process, as the statute at issue re-
quired only a “fair preponderance of the evidence” to support a
finding of permanent neglect. Id. at 747, 768. Along the way to
that conclusion, the Court referenced the “fundamental liberty in-
terest of natural parents in the care, custody, and management of
their child.” Id. at 753.
And Troxel concerned the constitutionality of Washington’s
statute that afforded “[a]ny person” the ability to petition a court
for visitation rights. 530 U.S. at 61 (plurality opinion). A plurality
of the Court said that this statute—which allowed a state court to
grant such rights if in the best interest of the child, even if the child’s
parent opposed—unconstitutionally infringed on “the fundamen-
tal right of parents to make decisions concerning the care, custody,
and control of their children,” as applied to facts of the case at issue.
Id. at 66–67.
We are not free to divorce the facts of these cases from the
rules they set forth. See, e.g., Edwards v. Prime, Inc., 602 F.3d 1276,
1298 (11th Cir. 2010) (“[R]egardless of what a court says in its opin-
ion, the decision can hold nothing beyond the facts of that case.”);
Watts v. BellSouth Telecomms., Inc., 316 F.3d 1203, 1207 (11th Cir.
2003) (“Whatever their opinions say, judicial decisions cannot
make law beyond the facts of the cases in which those decisions are
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 29 of 173
announced.”); Ogden v. Saunders, 25 U.S. (12 Wheat.) 213, 333
(1827) (Marshall, C.J., dissenting) (“[T]he positive authority of a de-
cision is co-extensive only with the facts on which it is made.”). As
the Supreme Court recently reminded, judicial “opinions dispose
of discrete cases and controversies and they must be read with a
careful eye to context.” Nat’l Pork Producers Council v. Ross, 598 U.S.
356, 373–74 (2023); accord Illinois v. Lidster, 540 U.S. 419, 424 (2004)
(explaining that courts should “read general language in judicial
opinions . . . as referring in context to circumstances similar to the
circumstances then before the Court and not referring to quite dif-
ferent circumstances that the Court was not then considering”).
Therefore, without an accompanying historical showing justifying
such a move, we cannot extend the holdings of these cases to the
facts here.
Both Judge Jordan and Judge Rosenbaum rely most heavily
on another case, Parham v. J. R., 442 U.S. 584 (1979). But no matter
how many times they turn to Parham, it does not “control[] the
analysis.” Rosenbaum Dis. Op. at 29. As we explained in the panel
opinion, Parham does not provide that the Fourteenth Amendment
guarantees parents the ability to disregard state regulations on
available medical care. Eknes-Tucker II, 80 F.4th at 1222–23. And a
sister circuit agrees. See L.W. ex rel. Williams v. Skrmetti, 83 F.4th
460, 477 (6th Cir. 2023) (“Nothing in Parham supports an affirma-
tive right to receive medical care, whether for a child or an adult,
that a state reasonably bans.”).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 30 of 173
In Parham, a group of minors brought a procedural-due-pro-
cess challenge to Georgia’s statutory scheme governing the admis-
sion of children to mental hospitals. 442 U.S. at 587–88. Im-
portantly, this scheme allowed parents to apply for their child’s
hospitalization. Id. at 590–91. Judges Jordan and Rosenbaum are
correct that the Court considered the interests of the parents in
reaching a conclusion as to the procedural protections owed to the
plaintiffs under the Due Process Clause. Id. at 601–04. Drawing
from its precedents, the Court said that a parent’s “high duty . . . to
recognize and prepare [their children] for additional obligations”
includes a duty to “recognize symptoms of illness and to seek and
follow medical advice.” Id. at 602 (second alteration in the original)
(quoting Pierce, 268 U.S. at 535). Because of this, the Court said that
the presence of disagreement between parent and child as to the
proper course of treatment “does not diminish the parents’ author-
ity to decide what is best for the child,” and does not provide cause
for governmental intervention. Id. at 603–04. With respect to vol-
untary commitment, the Court concluded that its precedents “per-
mit the parents to retain a substantial, if not the dominant, role in
the decision, absent a finding of neglect or abuse, and that the tra-
ditional presumption that the parents act in the best interests of
their child should apply.” Id. at 604. But, in light of “the child’s
rights and the nature of the commitment decision,” the Court also
cautioned that “parents cannot always have absolute and unre-
viewable discretion to decide whether to have a child institutional-
ized.” Id. Instead, the Court said, any decision is “subject to a phy-
sician’s independent examination and medical judgment.” Id.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 31 of 173
The Court ultimately concluded that “some kind of inquiry
should be made by a ‘neutral factfinder’ to determine whether the
statutory requirements for admission are satisfied,” but it rejected
a “formalized, factfinding hearing” because that could lead to a
“significant intrusion into the parent-child relationship.” Id. at 606,
610. “Pitting the parents and child as adversaries,” said the Court,
“often will be at odds with the presumption that parents act in the
best interests of their child.” Id. at 610.
In determining Parham’s relevance to this case, context is
again key. See Nat’l Pork Producers, 598 U.S. at 373–74. In other
words, we must not “rely[] on general statements from [Parham]
dealing with governmental actions not even remotely similar to
those involved here.” Parham, 442 U.S. at 608 n.16. While this case
is about a conflict between the Parent Plaintiffs and Alabama over
substantive-due-process requirements, Parham was concerned with
procedural-due-process requirements in a context that could pit
parents and children “as adversaries.” Id. at 610. And in Parham,
the question before the Court involved a Georgia law permitting
institutionalization as a state-approved form of medical treatment.
As we pointed out in the panel opinion, the question in Parham was
not whether, under the Fourteenth Amendment, a Georgia law
barring institutionalization had to give way in light of a parent’s de-
sire to institutionalize their child. See Eknes-Tucker II, 80 F.4th at
1223. Parham did not say, for example, that Georgia was constitu-
tionally forbidden from ending its voluntary commitment scheme
if parents disagreed with that decision. In fact, the Court indicated
that the opposite was true. See Parham, 442 U.S. at 604 (“Parents in
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 32 of 173
Georgia in no sense have an absolute right to commit their children
to state mental hospitals; the statute requires the superintendent of
each regional hospital to exercise independent judgment as to the
child’s need for confinement.”). The Parham Court also recognized
that “a state is not without constitutional control over parental dis-
cretion in dealing with children when their physical or mental
health is jeopardized.” Id. at 603. 11
Importantly, the Supreme Court later rejected an attempt to
turn Parham into the decision some of the dissenters want it to be.
In Cruzan ex rel. Cruzan v. Director, Missouri, Department of Health,
497 U.S. 261 (1990), the Court refused to read Parham, “a decision
which allowed a State to rely on family decisionmaking,” as setting
forth “a constitutional requirement that the State recognize such
11 Judge Rosenbaum states that this analysis “elementally misunderstands the
nature of a fundamental right,” as “[c]onstitutional protections are not so sus-
ceptible to state-law abrogation.” Rosenbaum Dis. Op. at 24; see also Jordan
Dis. Op. at 23–25. In the abstract, she is of course correct that a state law
cannot trump an individual right afforded by the federal constitution. But
here, we are tasked with the antecedent question: whether the Parent Plain-
tiffs are substantially likely to show that they have such a right in the first place.
To do so, we must consult text, history, and tradition, as informed by binding
precedent, to determine whether the Due Process Clause affords such a right
and strips Alabama of the authority to enforce the Act. See United States v.
Comstock, 560 U.S. 126, 159 (2010) (Thomas, J., dissenting) (“The States . . . are
free to exercise all powers that the Constitution does not withhold from
them.”). The point we made in the panel opinion, Eknes-Tucker II, 80 F.4th at
1223, is that Parham does not recognize the right claimed by the Parent Plain-
tiffs, and thus does not stand for the proposition that Alabama lacks the au-
thority to enforce the Act in light of parental dissent.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 33 of 173
decisionmaking.” Id. at 286. “[C]onstitutional law,” according to
the Court, “does not work that way.” Id.
Attempts to distinguish away Cruzan come up empty. Judge
Rosenbaum reads Parham to recognize a fundamental right and
then says that Cruzan, with its different facts, did not limit that
right. See Rosenbaum Dis. Op. at 19–23. But Cruzan did not distin-
guish Parham on any of the grounds offered by Judge Rosenbaum.
Instead, the Court in Cruzan disagreed with the petitioner’s view of
“constitutional law,” as evidenced by the petitioner’s reading of
Parham, which is like the reading offered by Judges Jordan and Ros-
enbaum. See Cruzan, 497 U.S. at 286. The panel’s refusal to adopt
a view of constitutional law rejected by the Supreme Court is
hardly “sidestep[ping]” Supreme Court precedent. Rosenbaum
Dis. Op. at 23.
In short, while some of the dissenters chant Parham “like a
mantra,” they “cannot give [Parham] substance that it lacks.” Sec.
& Exch. Comm’n v. Jarkesy, 144 S. Ct. 2117, 2138 (2024). Parham
does not lead to the conclusion that the Parent Plaintiffs have a
constitutional right to override Alabama’s decision regarding the
availability of the medications prohibited for use by minors under
the Act.
Thus, though purporting to simply apply Supreme Court
precedent, both Judge Jordan and Judge Rosenbaum would have
us mark out new terrain. 12 While the Supreme Court’s substantive-
12 This Court’s decisions similarly provide no support for the understanding of
the Due Process Clause shared by Judges Jordan and Rosenbaum, the district
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 34 of 173
due-process precedents do not rule out such a move, they do de-
mand a showing that a right is “deeply rooted in [our] history and
tradition” and “essential to our Nation’s ‘scheme of ordered lib-
erty.’” Dobbs, 597 U.S. at 237 (alteration in the original) (quoting
Timbs v. Indiana, 586 U.S. 146, 150 (2019)). To conduct this inquiry,
we must engage “in a careful analysis of the history of the right at
issue.” Id. at 238. This analysis is “essential whenever we are asked
to recognize a new component of the ‘liberty’ protected by the Due
Process Clause because the term ‘liberty’ alone provides little guid-
ance.” Id. at 239. It also guards against “usurp[ing] authority that
the Constitution entrusts to the people’s elected representatives”
and engaging in “freewheeling judicial policymaking.” Id. at 239–
40.
The approach taken by the district court—and by extension
those defending its decision—does not pay “careful ‘respect [to] the
teachings of history.’” Moore v. City of East Cleveland, 431 U.S. 494,
503 (1977) (plurality opinion) (quoting Griswold v. Connecticut, 381
U.S. 479, 501 (1965) (Harlan, J., concurring in the judgment)). The
Supreme Court’s opinion in Timbs traced the right at issue in that
case “back to [the] Magna Carta, Blackstone’s Commentaries, and
35 of the 37 state constitutions in effect at the ratification of the
court, and the Appellees. Eknes-Tucker II, 80 F.4th at 1223–24, 1223 n.15. Judge
Jordan criticizes the panel’s characterization of Bendiburg v. Dempsey, 909 F.2d
463 (11th Cir. 1990), Jordan Dis. Op. at 3–5, but I do not see how his criticism
ultimately supports his argument. In other words, even if we assume Bendi-
burg is “largely irrelevant,” id. at 5, this does not change the fact that this
Court’s cases do not support Judge Jordan’s reading of the Due Process Clause.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 35 of 173
Fourteenth Amendment.” Dobbs, 597 U.S. at 238 (citing Timbs, 586
U.S. at 151–54). And the Supreme Court’s opinion in Glucksberg
“surveyed more than 700 years of ‘Anglo-American common law
tradition.’” Id. at 239 (quoting Glucksberg, 521 U.S. at 711). But the
district court failed to point to any ratification-era support for its
decision—“no state constitutional provision, no statute, no judicial
decision, [and] no learned treatise.” Id. at 251; see Eknes-Tucker II,
80 F.4th at 1221 (“[T]he district court’s order does not feature any
discussion of the history of the use of puberty blockers or cross-sex
hormone treatment or otherwise explain how that history informs
the meaning of the Fourteenth Amendment at the time it was rat-
ified—July 9, 1868.”). 13
Judges Jordan and Rosenbaum similarly fail to supply the
needed historical support. This holds true even if we assume that
they correctly framed the alleged right at stake. Finding the proper
level of specificity does not exempt one from “engag[ing] in a care-
ful analysis of the history of the right at issue.” Dobbs, 597 U.S. at
238. And neither Judge Jordan nor Judge Rosenbaum has demon-
strated that the ability to obtain medically-approved or non-exper-
imental treatment, despite state regulation to the contrary, is
13 A word about the so-called “1868 Methodology.” See Rosenbaum Dis. Op.
at 1–2, 32–37. Judge Rosenbaum mischaracterizes the panel opinion as con-
cluding that parents have the fundamental right to direct that their children
receive “medical treatments in existence as of 1868.” Id. at 1. That issue, of
course, was not before the panel. And the panel opinion merely notes the
absence of any historical support for the position reached by the district
court—a deficiency not cured on appeal.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 36 of 173
“deeply rooted in [our] history and tradition.” Id. at 237 (alteration
in the original) (quoting Timbs, 586 U.S. at 150). If their understand-
ing of the Due Process Clause was correct, we would expect to see
some evidence of such a right’s existence before and after the Four-
teenth Amendment’s ratification. But, at least on the arguments
presented in this case, no one comes close to demonstrating the
existence of a right “deeply rooted in this Nation’s history and tra-
dition” and “implicit in the concept of ordered liberty.” Id. at 231
(quoting Glucksberg, 521 U.S. at 721).
This lack of history should not be surprising given that
“States traditionally have had great latitude under their police pow-
ers to legislate as to the protection of the lives, limbs, health, com-
fort, and quiet of all persons.” Medtronic, Inc. v. Lohr, 518 U.S. 470,
475 (1996) (quoting Metro. Life Ins. Co. v. Massachusetts, 471 U.S. 724,
756 (1985)); cf. Muñoz, 144 S. Ct. at 1823 (refusing to recognize a
right under Glucksberg when “the through line of history” is recog-
nition of the government’s power to regulate). Included within
these police powers is the authority to legislate to “preserv[e] and
promot[e] the welfare of the child,” Santosky, 455 U.S. at 766, and
to “safeguard[] the physical and psychological well-being of a mi-
nor,” Globe Newspaper Co. v. Superior Ct. for Norfolk Cnty., 457 U.S.
596, 607 (1982), even if, in some cases, this limits parental discre-
tion, see Prince, 321 U.S. at 167. Indeed, the Supreme Court has
“sustained legislation aimed at protecting the physical and emo-
tional well-being of youth even when the laws have operated in the
sensitive area of constitutionally protected rights.” New York v. Fer-
ber, 458 U.S. 747, 757 (1982).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 37 of 173
Importantly, a state’s exercise of this authority is not contin-
gent on the approval of the expert class. The Constitution’s con-
tours are not shaped by expert opinion. See Dobbs, 597 U.S. at 272–
73 (suggesting that the position of groups like the American Medi-
cal Association does not “shed light on the meaning of the Consti-
tution”); Otto v. City of Boca Raton, 981 F.3d 854, 869 (11th Cir. 2020)
(explaining that “institutional positions cannot define the bounda-
ries of constitutional rights”). “[F]rom time immemorial,” the
states have regulated those who practice medicine. Dent v. West
Virginia, 129 U.S. 114, 122 (1889); see Watson v. Maryland, 218 U.S.
173, 176 (1910) (“It is too well settled to require discussion at this
day that the police power of the states extends to the regulation of
certain trades and callings, particularly those which closely concern
the public health.”). And the Due Process Clause does not mandate
the opposite arrangement.
Additionally, neither Judge Jordan nor Judge Rosenbaum
has assembled a historical record demonstrating that adults them-
selves possess the constitutional right to access the medications at
issue, or any specific medication, for that matter. And the weight
of the authority indicates that the opposite is true. Many of our
sister circuits “have rejected arguments that the Constitution pro-
vides an affirmative right of access to particular medical treatments
reasonably prohibited by the Government.” Abigail All. for Better
Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695, 710
(D.C. Cir. 2007) (en banc); see id. at 710 n.18 (collecting cases);
Mitchell v. Clayton, 995 F.2d 772, 775 (7th Cir. 1993) (“[M]ost federal
courts have held that a patient does not have a constitutional right
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 38 of 173
to obtain a particular type of treatment or to obtain treatment from
a particular provider if the government has reasonably prohibited
that type of treatment or provider.”). Instead, “our Nation’s his-
tory evidences increasing regulation of drugs as both the ability of
government to address these risks has increased and the risks asso-
ciated with drugs have become apparent.” Abigail All., 495 F.3d at
711. Because we have recognized that a parent’s right to “make
decisions for his [son or daughter] can be no greater than his rights
to make medical decisions for himself,” Doe ex rel. Doe v. Pub. Health
Tr. of Dade Cnty., 696 F.2d 901, 903 (11th Cir. 1983), these cases
strongly support the result reached by the panel opinion. This is
especially true because the “state’s authority over children’s activi-
ties is broader than over like actions of adults.” Prince, 321 U.S. at
168.
For all these reasons, the panel was correct to conclude that
the Parent Plaintiffs have failed to establish the existence of a fun-
damental right. I write further, though, to highlight additional
doubts that I have about the Parent Plaintiffs’ arguments.
First, even if the historical record lent credence to the idea
that there was a parental right to obtain medically approved or
non-experimental medications in the face of governmental prohi-
bition, I am skeptical that this right would be implicated here. “[I]n
areas where there is medical and scientific uncertainty,” state legis-
latures are afforded “wide discretion to pass legislation.” Gonzales
v. Carhart, 550 U.S. 124, 163 (2007). And with this wide discretion
comes an exceedingly narrow role for federal courts. If it were
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 39 of 173
otherwise, we would often find ourselves answering questions that
should be answered by the political branches. Instead of merely
“say[ing] what the law is,” Marbury v. Madison, 5 U.S. (1 Cranch)
137, 177 (1803), we would be “decid[ing] the proper balance be-
tween the uncertain risks and benefits of medical technology,” Ab-
igail All., 495 F.3d at 713, and imposing a “constitutional straight-
jacket” in the process, Skrmetti, 83 F.4th at 473. That is not our role.
Below, the district court extended the Constitution’s protec-
tions despite considerable uncertainty, based in part on its conclu-
sion that Alabama failed to produce “evidence showing that transi-
tioning medications jeopardize the health and safety of minors suf-
fering from gender dysphoria.” Eknes-Tucker I, 603 F. Supp. 3d at
1145. But that statement is not quite right. 14 As I explain in my
discussion of rational-basis review, Alabama did in fact produce ev-
idence to that effect. 15 See infra at 43–47. And recent revelations
only serve to confirm the impropriety of the district court’s inter-
vention. I make note of them not because they change our review
of the district court’s order, but because they highlight the issues
14 Indeed, elsewhere in its order, the district court recognized that “transition-
ing medications” come with “[k]nown risks,” including “loss of fertility and
sexual function.” Eknes-Tucker I, 603 F. Supp. 3d at 1139; see also id. at 1145
(recognizing that the “Defendants offer some evidence that transitioning med-
ications pose certain risks”).
15 For example, studies suggest that significant health risks may stem from the
use of these medications, including sterility, sexual dysfunction, lower bone
density, high blood pressure, breast cancer, liver disease, cardiovascular dis-
ease, and weight gain.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 40 of 173
that often arise when courts extend the Constitution’s protections
to areas subject to all sorts of uncertainty.
For example, when the district court entered the order un-
der review, it concluded that “no country or state in the world cat-
egorically bans the[] use” of puberty blockers and cross-sex hor-
mones “as Alabama has.” Eknes-Tucker I, 603 F. Supp. 3d at 1145.
But other countries have started to adopt Alabama’s position. In
March 2024, England’s NHS announced that puberty blockers are
no longer available as a routine treatment for English minors suf-
fering from gender dysphoria. NHS “concluded that there is not
enough evidence to support the safety or clinical effectiveness” of
such drugs “to make the treatment routinely available at this
time.” 16 NHS Clinical Policy, supra n.3, at 3. And as noted earlier,
the UK has also temporarily banned puberty blockers (with limited
exceptions) through an emergency order, which the UK’s High
Court recently sustained. See TransActual CIC [2024] EWHC 1936
(Admin), ¶¶ 142–48, 257.
The district court also relied heavily on the Standards of
Care promulgated by WPATH, Eknes-Tucker I, F. Supp. 3d at 1138–
39, 1145, which one dissenter considers the “leading authority” in
16 NHS has also placed severe restrictions on “gender affirming hormones,”
allowing for their use only after a child has turned sixteen and meets several
other criteria. See Prescribing of Gender Affirming Hormones (masculinising or fem-
inising hormones) as part of the Children and Young People’s Gender Service, Nat’l
Health Serv., Eng., (Mar. 21, 2024), https://www.england.nhs.uk/wp-con-
tent/uploads/2024/03/clinical-commissioning-policy-prescribing-of-gender-
affirming-hormones.pdf [https://perma.cc/Q2TX-5KWP].
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 41 of 173
this area. Rosenbaum Dis. Op. at 29. But recent revelations indi-
cate that WPATH’s lodestar is ideology, not science. For example,
in one communication, a contributor to WPATH’s most recent
Standards of Care frankly stated, “[o]ur concerns, echoed by the
social justice lawyers we spoke with, is that evidence-based review
reveals little or no evidence and puts us in an untenable position in
terms of affecting policy or winning lawsuits.” This only reinforces
the district court’s improper reliance on the scientific claims of an
advocacy organization to craft constitutional law. Indeed, as oth-
ers have recognized, WPATH’s Standards of Care “reflect not con-
sensus, but merely one side in a sharply contested medical debate
over sex reassignment surgery.” Gibson v. Collier, 920 F.3d 212, 221
(5th Cir. 2019); see also Edmo v. Corizon, Inc., 949 F.3d 489, 497 (9th
Cir. 2020) (O’Scannlain, J., opinion respecting the denial of rehear-
ing en banc) (“The WPATH Standards are merely criteria promul-
gated by a controversial private organization with a declared point
of view.”). 17
These revelations only further underscore the reality that a
judge is not fit, in a preliminary posture and on a limited record, to
remove matters like this one from an ongoing public debate. Even
assuming parents possessed a right to compel access to certain
17 As the Fifth Circuit went on to explain, one of the doctors who helped draft
a previous edition of WPATH’s Standards of Care testified that the Standards
of Care “is not a politically neutral document.” Gibson, 920 F.3d at 222 (em-
phasis omitted) (quoting Kosilek v. Spencer, 774 F.3d 63, 78 (1st Cir. 2014) (en
banc)). Instead, “WPATH aspires to be both a scientific organization and an
advocacy group for the transgendered.” Id. (quoting Kosilek, 774 F.3d at 78).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 42 of 173
medical treatments for their children, this right certainly does not
include the ability to access substances that gravely threaten a
child’s development. Cf. Prince, 321 U.S. at 165 (“It is the interest
of youth itself, and of the whole community, that children be both
safeguarded from abuses and given opportunities for growth into
free and independent well-developed men and citizens.”). And if it
turns out that the substances at issue here have such effects, a judi-
cial ruling to the contrary would facilitate, rather than prevent, ir-
reparable harm.
Some substantive-due-process cases may be hard. Jordan
Dis. Op. at 1. This one is not. Judge Jordan reminds us “that it is a
constitution we are expounding.” Jordan Dis. Op. at 2 (alteration
adopted) (quoting Home Bldg. & Loan Ass’n v. Blaisdell, 290 U.S. 398,
443 (1934)). 18 But “[p]recisely because ‘it is a constitution we are
expounding,’ we ought not to take liberties with it.” Nat’l Mut. Ins.
Co. of Dist. Of Col. v. Tidewater Transfer Co., 337 U.S. 582, 647 (1949)
(Frankfurter, J., dissenting) (quoting McCulloch v. Maryland, 17 U.S.
(4 Wheat.) 316, 407 (1819)). Our legal tradition rightly entrusts par-
ents with broad authority in the lives of their children. But that
18 As Justice Scalia explained, this line from Chief Justice Marshall has long
been misread to justify interpreting the Constitution in a way that is un-
moored from its text and history. See Antonin Scalia, Essay: Assorted Canards
of Contemporary Legal Analysis, 40 Case W. Res. L. Rev. 581, 594–96 (1989); see
also Ogden, 25 U.S. (12 Wheat.) at 332 (Marshall, C.J., dissenting) (The Consti-
tution’s words “are to be understood in that sense in which they are generally
used by those for whom the instrument was intended [and] its provisions are
neither to be restricted into insignificance, nor extended to objects not com-
prehended in them, nor contemplated by its framers.”).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 43 of 173
tradition also provides no basis for concluding that this authority
extends to the circumstances presented by this case. The district
court thus erred by applying heightened scrutiny. The Act need
only satisfy the rational-basis test, and the Parent Plaintiffs do not
have a substantial likelihood of success in arguing that it does not.
See infra at 42–52.
B. Equal Protection
Judge Rosenbaum’s and Judge Wilson’s dissents also disa-
gree with our equal-protection holding, arguing that the Act dis-
criminates based on sex and transgender status. Rosenbaum Dis.
Op. at 46–63; Wilson Dis. Op. at 3–5. But the Act applies equally
to everyone regardless of their sex or transgender status. And
transgender status is not a classification protected by the Equal Pro-
tection Clause. These points are discussed in turn below.
1. The Act does not discriminate based on sex.
Supposedly, the Act unconstitutionally discriminates based
on sex because “but for the Minors’ birth-assigned sex,” they could
access puberty blockers and cross-sex hormones. Rosenbaum Dis.
Op. at 49. For example, Judge Rosenbaum notes that the Act pro-
hibits a “birth-assigned boy” from “tak[ing] estrogen” for the pro-
scribed purpose while a “birth-assigned girl” can take estrogen to
cure “an estrogen deficiency.” Id. In other words, Judge Rosen-
baum argues that the Equal Protection Clause requires Alabama to
make cross-sex hormones and puberty blockers available for the
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 44 of 173
proscribed purpose so long as Alabama allows the use of puberty
blockers and cross-sex hormones for other purposes.
Therein lies the problem with her reasoning: The Act dis-
criminates based on purpose, not sex. The Act prohibits everyone
under the age of nineteen—regardless of their sex—from using
cross-sex hormones or puberty blockers “for the purpose of attempt-
ing to alter the appearance of or affirm [their] perception of [their]
gender or sex, if that appearance or perception is inconsistent with
[their] sex.” Act § 3–4(a) (emphasis added); Ala. Code § 43-8-1(18).
Likewise, the Act allows everyone under the age of nineteen—re-
gardless of their sex—to use cross-sex hormones and puberty block-
ers for other purposes, such as treating central precocious puberty.
Act § 4(b)(2).
True, the Act uses sex-specific terminology. See Wilson Dis.
Op. at 4–5. The Act prohibits prescribing or administering “su-
praphysiologic doses of testosterone . . . to females” and prescrib-
ing or administering “supraphysiologic doses of estrogen to males.”
Act § 4(a)(2)–(3). But this sex-specific language actually preserves
evenhandedness. Because of biological realities, the cross-sex hor-
mone regimen that one undergoes is necessarily dependent on
one’s sex. Males cannot use testosterone for the prohibited pur-
pose, and females cannot use estrogen for the prohibited purpose.
To the extent that the Act includes provisions that reference only
one sex, see id., it simply reflects these realities to equally proscribe
cross-sex hormones for both males and females. If the Act re-
stricted only the use of testosterone—but not estrogen—for the
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 45 of 173
proscribed purpose, it would discriminate against females. And if
the Act restricted only the use of estrogen—but not testosterone—
for the proscribed purpose, it would discriminate against males. In
other words, the Act uses sex-specific language because it regulates
sex-specific medications. And, as noted in our panel opinion, “[t]he
regulation of a medical procedure that only one sex can undergo
does not trigger heightened constitutional scrutiny unless the reg-
ulation is a ‘mere pretex[t] designed to effect an invidious discrim-
ination against members of one sex or the other.’” Eknes-Tucker II,
80 F.4th at 1229 (alterations in the original) (quoting Dobbs, 597 U.S.
at 236).
Judge Rosenbaum and Judge Wilson both invoke Bostock v.
Clayton County, 590 U.S. 644 (2020). Rosenbaum Dis. Op. at 50, 54–
56; Wilson Dis. Op. at 3–4. But the meaning of the Equal Protec-
tion Clause was not at issue in Bostock, and the Supreme Court ex-
pressly declined to “prejudge” whether its reasoning applied to
other laws “that prohibit sex discrimination.” Bostock, 590 U.S. at
681. Notwithstanding Bostock’s limited holding, Judge Rosenbaum
reads Bostock to announce a new principle that applies to every anti-
discrimination provision in federal law, including a constitutional
provision that was ratified in 1868. Supposedly, after Bostock, all
classifications “based on transgender status” are classifications
“based on sex.” Rosenbaum Dis. Op. at 54. That reading ignores
the reasoning in Bostock.
Bostock relied heavily on the unique text of Title VII—
particularly, the words “because of,” “otherwise . . . discriminate
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 46 of 173
against,” and “individual.” Eknes-Tucker II, 80 F.4th at 1228–29 (al-
teration in the original) (quoting Bostock, 590 U.S. at 656–58); see 42
U.S.C. § 2000e-2(a)(1). The Equal Protection Clause does not in-
clude any of this language. See U.S. Const. amend. XIV, § 1 (“No
State shall . . . deny to any person within its jurisdiction the equal
protection of the laws.”). As Justice Gorsuch—the author of Bos-
tock—observed when comparing the text of Title VI and the text of
the Equal Protection Clause, it “is implausible on its face” that
“such differently worded provisions should mean the same thing.”
Students for Fair Admissions, Inc. v. President & Fellows of Harvard
Coll., 600 U.S. 181, 308 (2023) (Gorsuch, J., concurring). Justice
Gorsuch’s point is no less relevant to Title VII and the Equal Pro-
tection Clause. See Skrmetti, 83 F.4th at 484 (finding that the rea-
soning of Bostock “applies only to Title VII”); Brandt ex rel. Brandt v.
Rutledge, No. 21-2875, 2022 WL 16957734, at *1 n.1 (8th Cir. Nov.
16, 2022) (Stras, J., dissenting from denial of rehearing en banc) (ex-
pressing skepticism that Bostock’s reasoning applies to the Equal
Protection Clause because the Fourteenth Amendment “predates
Title VII by nearly a century” and contains language that is “not
similar in any way” to Title VII’s); cf. Fowler v. Stitt, 104 F.4th 770,
801–02 (10th Cir. 2024) (Hartz, J., dissenting in part) (disagreeing
with the majority’s reflexive application of Bostock to the Equal Pro-
tection Clause). Because the language of the Equal Protection
Clause does not resemble the language of Title VII, Bostock’s rea-
soning does not apply here.
Next, two dissents cite Glenn v. Brumby, 663 F.3d 1312 (11th
Cir. 2011), and both claim that we distinguished Brumby by
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 47 of 173
confining it to employment discrimination. Rosenbaum Dis. Op.
at 57; Wilson Dis. Op. at 3–4. Respectfully, the majority opinion
and Judge Brasher’s concurrence explained that Brumby is distin-
guishable because Brumby dealt with sex-based stereotypes about
how men should dress, not biological realities. Eknes-Tucker II, 80
F.4th at 1229 (“Insofar as section 4(a)(1)–(3) involves sex, it simply
reflects biological differences between males and females, not ste-
reotypes associated with either sex.”); id. at 1234 (Brasher, J., con-
curring) (“Unlike the employer’s decision in [Brumby], Alabama’s
statute does not fit the mold of a sex-based stereotype. The statute
isn’t based on a socially constructed generalization about the way
men or women should behave.”).
Judge Rosenbaum responds that it is a form of stereotyping
to prohibit minors from taking transitioning medications. See Ros-
enbaum Dis. Op. at 52–53. But there is a difference between pro-
hibiting biological men from wearing dresses, see Brumby, 663 F.3d
at 1314, 1318–19, and prohibiting minor boys from taking estrogen
“for the purpose of attempting to alter the appearance of or affirm
the minor’s perception of his . . . gender or sex, if that appearance
or perception is inconsistent with [his] sex,” Act § 4(a). The former
restriction is a stereotype about how men should dress, the latter
restriction is based on physical differences between males and fe-
males. And, as the Supreme Court has recognized, “[p]hysical dif-
ferences between men and women . . . are enduring.” United States
v. Virginia, 518 U.S. 515, 533 (1996). The recognition of those phys-
ical differences, which are inherent in the biology of every man and
woman, “is not a stereotype.” Nguyen v. I.N.S., 533 U.S. 53, 68
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 48 of 173
(2001); see also Eknes-Tucker II, 80 F.4th at 1234 (Brasher J., concur-
ring).
Overall, the Act applies equally to minor males and minor
females. Both sexes can use puberty blockers and cross-sex hor-
mones to treat a medical disorder, Act § 4(b)(2), but neither sex
may use puberty blockers and cross-sex hormones “for the purpose
of attempting to alter the appearance of or affirm [their] perception
of [their] gender or sex, if that appearance or perception is incon-
sistent with [their] sex.” Id. § 4(a). Thus, our panel correctly held
that the Act is subject to rational-basis scrutiny, not intermediate
scrutiny. Eknes-Tucker II, 80 F.4th at 1230.
2. The text of the Act is neutral as to transgender status, and
transgender status is not a quasi-suspect classification.
Judge Rosenbaum also claims that the Act triggers interme-
diate scrutiny because transgender status is a quasi-suspect classifi-
cation. Rosenbaum Dis. Op. at 58–63. But as our panel opinion
explained, even if transgender status is a quasi-suspect classifica-
tion, the Act would not trigger heightened scrutiny because it dis-
criminates solely based on “purpose.” Act § 4(a); Eknes-Tucker II,
80 F.4th at 1228. Under the plain terms of the Act, any minor can
access puberty blockers and cross-sex hormones for an acceptable
purpose, such as treating central precocious puberty. Act
§ 4(b)(2). 19 To be sure, a facially evenhanded regulation can be
19 Judge Rosenbaum also states that people are not truly “transgender” if they
“experience some form of gender incongruence” but “ultimately embrace
their birth-assigned gender or detransition.” Rosenbaum Dis. Op. at 59. But
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 49 of 173
subject to heightened scrutiny if it is a mere pretext for invidious
discrimination against a protected class. See Shaw v. Reno, 509 U.S.
630, 643–44 (1993). But the district court made no findings of such
a pretext here. Judge Rosenbaum’s argument fails on this point
alone.
More generally, transgender status is not a quasi-suspect
classification in the first place. While sitting en banc, we already
declined to recognize transgender status as a quasi-suspect classifi-
cation. See Adams ex rel. Kasper v. Sch. Bd. of St. Johns Cnty., 57 F.4th
791, 803 n.5 (11th Cir. 2022) (en banc) (expressing “grave ‘doubt’
that transgender persons constitute a quasi-suspect class”). Fur-
ther, the Supreme Court “has not recognized any new constitu-
tionally protected classes in over [five] decades, and instead has re-
peatedly declined to do so.” Ondo v. City of Cleveland, 795 F.3d 597,
609 (6th Cir. 2015). Since 1973, the Supreme Court has declined to
recognize poverty, age, and mental disability as suspect or quasi-
suspect classifications. See San Antonio Indep. Sch. Dist. v. Rodriguez,
411 U.S. 1, 28–29 (1973) (poverty); Massachusetts Bd. of Ret. v. Mur-
gia, 427 U.S. 307, 313–14 (1976) (age); City of Cleburne v. Cleburne
Living Ctr., 473 U.S. 432, 442 (1985) (mental disability); see also Lyng
if that’s true, then not everyone who seeks medications “for the purpose of
attempting to alter the appearance of” their “sex,” is, in fact, transgender. Act
§ 4(a). Thus, if Judge Rosenbaum is correct, then the Act does not discriminate
based on transgender status—not everyone who seeks the relevant medication
for the relevant purpose would, in fact, be transgender.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 50 of 173
v. Castillo, 477 U.S. 635, 638 (1986) (“Close relatives are not a ‘sus-
pect’ or ‘quasi-suspect’ class.”).
Judge Rosenbaum would chart new territory by treating
transgender status as a quasi-suspect classification. The district
court never held that, see Eknes-Tucker I, 603 F. Supp. 3d at 1146–
48, and neither Judge Rosenbaum’s dissent nor Judge Wilson’s dis-
sent cite any record evidence suggesting that transgender persons
are a “discrete group” defined by “obvious, immutable, or distin-
guishing characteristics” and that they are “politically powerless.”
Lyng, 477 U.S. at 638. Unlike race, sex, or national origin,
transgender status is not “an immutable characteristic determined
solely by the accident of birth.” Frontiero v. Richardson, 411 U.S.
677, 686 (1973). Studies show that 61% to 88% of children with
gender dysphoria become comfortable with their sex “over the
course of puberty.” A trait is not “immutable” if it is “subject
to . . . change.” Adams, 57 F.4th at 807 (quoting Immutable, Oxford
English Dictionary (2d ed. 1989)).
Furthermore, transgender persons are not a “discrete
group” that exhibits “obvious” or “distinguishing” characteristics.
Lyng, 477 U.S. at 638. WPATH itself defines “transgender” as an
“[a]djective” used to describe anyone “who cross[es] or trans-
cend[s] culturally defined categories of gender.” Possible gender
identities described by WPATH and the American Psychological
Association include “boygirl,” “girlboy,” “genderqueer,” “bi-
gender,” “pangender,” “androgyne,” “genderless,” “gender neu-
tral,” “neutrois,” “agender,” and “genderfluid,” just to name a few.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 51 of 173
According to the American Psychological Association, possible
gender identities exist on a “wide spectrum” that defies the binary
nature of sex. That theory has no practical limits. Also, one of the
dissents argues that people are not truly “transgender” if they “ex-
perience some form of gender incongruence” but “ultimately em-
brace their birth-assigned gender or detransition.” Rosenbaum
Dis. Op. at 59. But if that’s true, then someone who currently iden-
tifies as a “boygirl,” for example, might not actually be transgender
based on their future self-perceptions or actions. A classification is
neither “obvious” nor “distinguishing” if it turns on a future that is
presently unknown. Like Rodriguez, this case “comes to us with no
definitive description of the classifying facts or delineation of the
disfavored class.” 411 U.S. at 19.
Finally, transgender people are not “politically powerless.”
Lyng, 477 U.S. at 638. “A national anti-discrimination law, Title VII,
protects transgender individuals in the employment setting,” and
“[f]ourteen States have passed laws specifically allowing some of
the treatments sought here.” Skrmetti, 83 F.4th at 487. The White
House recognizes an annual “Transgender Day of Visibility.” See
Proclamation No. 10724, 89 Fed. Reg. 22901 (March 29, 2024). The
Department of Justice is devoting considerable time and resources
as an intervenor plaintiff in this litigation. Twenty states and the
District of Columbia filed an amicus brief in support of the Plain-
tiffs. And every major law firm that has participated in this litiga-
tion has supported the Plaintiffs. All of these facts contradict a no-
tion of political powerlessness. True, Judge Rosenbaum cites sta-
tistics about the lamentable harassment that transgender people
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 52 of 173
experience, Rosenbaum Dis. Op. at 60–61, but Cleburne is clear that
“some degree of prejudice from at least part of the public at large”
is not sufficient. 473 U.S. at 445. Significantly, in Cleburne, the Su-
preme Court rejected the argument that mental disability is a sus-
pect classification, id. at 442–46, despite a history of compulsory
sterilization, exclusion from public schools, and a system of “state-
mandated segregation and degradation” “that in its virulence and
bigotry rivaled, and indeed paralleled, the worst excesses of Jim
Crow,” id. at 462–63 (Marshall, J., concurring in the judgment and
dissenting in part). And since Cleburne, the Supreme Court has
never recognized a new suspect or quasi-suspect classification.
Neither the Plaintiffs, nor the district court, nor the dissenters have
provided a basis for us to do so here.
Because the Act does not discriminate based on a suspect or
a quasi-suspect classification, the Act is subject to rational-basis re-
view. Id. at 440, 446. To satisfy rational-basis review, Alabama
needs only one “conceivable basis” to proscribe cross-sex hor-
mones and puberty blockers for minors. See Jones v. Governor of Flor-
ida, 975 F.3d 1016, 1034 (11th Cir. 2020) (en banc) (quoting FCC v.
Beach Commc’ns, Inc., 508 U.S. 307, 315 (1993)). As explained in the
next section, there are many conceivable bases for the Act, and
thus, the Plaintiffs lack a substantial likelihood of success on their
due process and equal protection claims.
C. Rational-Basis Review
Under rational-basis review, the question “is simply whether
the challenged legislation is rationally related to a legitimate state
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 53 of 173
interest.” Lofton v. Sec’y of Dep’t of Child. & Fam. Servs., 358 F.3d
804, 818 (11th Cir. 2004). Alabama satisfied this remarkably lenient
standard for at least five reasons.
First, Alabama provided significant evidence that the medi-
cations covered by the Act are dangerous and ineffective. Alt-
hough the district court disagreed with that evidence, it acknowl-
edged that Alabama “offer[ed] some evidence that transitioning
medications pose certain risks.” Eknes-Tucker I, 603 F. Supp. 3d at
1145. That is sufficient to satisfy the rational-basis test. The Ala-
bama legislature is entitled to look at the competing evidence and
draw its own conclusions. Heller, 509 U.S. at 319 (“[R]ational-basis
review in equal protection analysis ‘is not a license for courts to
judge the wisdom, fairness, or logic of legislative choices.’” (quot-
ing Beach Commc’ns, 508 U.S. at 313)). To be sure, Alabama did not
need to cite any “evidence or empirical data” supporting the Act.
Beach Commc’ns, 508 U.S. at 315. “[R]ational speculation” would
have been sufficient. Id. Even so, Alabama’s evidence of the dan-
gers of cross-sex hormones and puberty blockers was legion.
Alabama provided declarations from six medical experts—
three endocrinologists (including two pediatric endocrinologists),
a clinical psychologist, a psychotherapist, and a pediatrician—who
testified to the acute dangers posed to children by these medica-
tions. Alabama also submitted six journal articles and public-health
reports that documented concerning data and evidence about the
proscribed treatments. And Alabama provided written testimony
from detransitioners, including Sydney Wright (discussed above),
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 54 of 173
KathyGrace Duncan (Appendix A), Carol Frietas (Appendix B), and
Corinna Cohn (Appendix C). Although the district court’s order
discussed the testimony of Dr. James Cantor and Sydney Wright,
the district court never mentioned any of the other evidence de-
scribed in this paragraph. See Eknes-Tucker I, 603 F. Supp. 3d at
1142–43, 1145–46.
Alabama also presented evidence that healthcare authorities
and medical organizations in several countries—including Eng-
land, Finland, and Sweden—urge (and, in some cases, mandate)
that doctors rarely prescribe puberty blockers and cross-sex hor-
mones. In Sweden, for example, doctors can provide minors with
puberty blockers and cross-sex hormones in “exceptional cases”
only. Sweden’s National Board of Health and Welfare determined
that “the risks of puberty suppressing treatment with GnRH-ana-
logues and gender-affirming hormonal treatment currently out-
weigh the possible benefits.”
The information that has emerged since the panel’s opinion
only confirms what the panel already concluded: Alabama has a
rational basis for the Act. As discussed earlier, in March 2024, for
example, England’s NHS announced “that there is not enough ev-
idence to support the safety or clinical effectiveness of [puberty
suppressing hormones] to make the treatment routinely available”
in England. NHS Clinical Policy, supra n.3, at 3. And, in April 2024,
Dr. Hillary Cass published the results of a four-year review of pu-
berty blockers and cross-sex hormones in minors. See The Cass Re-
view, supra n.2. While formulating her report, Cass chaired a
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 55 of 173
policy working group that the NHS commissioned in January 2020.
Id. at 75. The policy working group systematically examined “the
published evidence on the use of puberty blockers and [cross-sex]
hormones in children and young people” with the goal of “in-
form[ing] [NHS’s] policy position on their future use.” Id. Cass
found “no evidence that puberty blockers improve body image or
dysphoria, and very limited evidence for positive mental health
outcomes.” Id. at 179. Cass also concluded that puberty blockers
may negatively impact “neurocognitive development” and will
likely compromise a patient’s “bone density.” Id. at 178. Regarding
cross-sex hormones, Cass’s “systematic review” found inadequate
evidence supporting the “widespread” view—expressed in Judge
Rosenbaum’s dissent—that cross-sex hormones “reduce[] suicide
risk” for children suffering from gender dysphoria. Id. at 186, 195.
Cass also provided multiple reasons to question the reliability of
WPATH and concluded that the most recent iteration of the Stand-
ards of Care “overstates the strength of the evidence” supporting
its recommendations. Id. at 132; see also id. at 129–30 (concluding
that WPATH’s Standards suffer from a low “[r]igour of develop-
ment” and the lack of “[e]ditorial independence,” among other
things).
Second, Alabama had a rational basis to prohibit cross-sex
hormones and the other proscribed medications for minors be-
cause minors cannot appreciate the life-altering nature of the med-
ical treatments. The law frequently limits the ability of minors to
consent to certain activities. And evidence in the record suggests
that minors are incapable of knowingly consenting to the use of the
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 56 of 173
proscribed medications. Alabama presented evidence from many
detransitioners who uniformly testified that they were not aware
of the long-term impacts of the treatments they underwent. Next,
Alabama provided declarations from several parents who testified
to the negative effects of cross-sex hormones and puberty blockers
on their children, even if their children suffered from gender dys-
phoria and desired medical transition. Furthermore, Alabama pre-
sented written testimony from nine parents who said that doctors,
therapists, and other practitioners pressured them to start their
children on cross-sex hormones and puberty blockers or otherwise
circumvented their wishes. For example, when one mother’s
twelve-year-old daughter said that she was a boy, the mother asked
her daughter’s gender clinic for a counseling referral before hor-
mone therapy. But an endocrinologist rebuffed the mother’s re-
quest, stating in front of the twelve-year-old daughter that the
mother needed “to get on board” with providing puberty blockers
and hormones if she did not “want [her] daughter to commit sui-
cide.”
This record evidence is consistent with information that has
come to light after the district court issued its order. As Dr. Cass
found in her April 2024 study, we know very little about the long-
term risks of these medications, which makes the idea of “informed
consent” nearly impossible for anyone, but especially for children
and adolescents. See The Cass Review, supra n.2, at 193–97.
Third, as discussed above, studies show that most children
with gender dysphoria grow out of it. As one of Alabama’s experts
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 57 of 173
testified, “every study without exception has come to the identical
conclusion: Among prepubescent children who feel gender dys-
phoric, the majority cease to want to be the other gender over the
course of puberty—ranging from 61–88% desistance across the
large, prospective studies.” Alabama also presented evidence that
children are starting to identify as transgender because of social
contagion, not gender dysphoria. Teenage girls, in particular, are
starting to suddenly identify as transgender even if they have no
history of gender dysphoria as children. And, according to one of
Alabama’s experts, “[t]he majority of cases appear to occur within
clusters of peers and in association with increased social media use
and especially among people with autism or other neurodevelop-
mental or mental health issues.” Even the Plaintiffs’ expert, Dr.
Linda Hawkins, testified that gender clinics are “seeing an increase
in youth . . . who are exploring gender . . . . [T]hat is something
that is gaining popularity right now.” Alabama has a legitimate in-
terest in preventing harm to children who often do not suffer from
gender dysphoria, and even if they do, likely will grow out of it. It
is thus rational to require children to wait to undergo this type of
medical treatment until they are adults.
Fourth, notwithstanding assurances from organizations like
WPATH, there are significant unknowns about these treatments,
which recent developments only serve to highlight. The district
court’s order relied on WPATH’s Standards of Care, Eknes-Tucker
I, 603 F. Supp. 3d at 1138–39, which claim to provide “the highest
standards” for “safe,” “effective,” and “evidence-based” treatment
for people suffering from gender dysphoria. Judge Rosenbaum also
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 58 of 173
suggests that courts should look to WPATH’s Standards of Care
for narrow tailoring purposes. Rosenbaum Dis. Op. at 44. But a
March 2024 leak of documents and audio recordings suggests that
WPATH is not genuine in its claim that these treatments are safe,
effective, and well understood, particularly for minors. See The
WPATH Files, supra n.4, at 72–241.
For instance, in a leaked recording of a WPATH Panel, Dr.
Daniel Metzger—an endocrinologist—frankly discussed the diffi-
culties of helping children and adolescents understand the effects
of cross-sex hormones and puberty blockers. Id. at 184–85. He
acknowledged, “the thing you have to remember about kids is that
we’re often explaining these sorts of things to people who haven’t
even had biology in high school yet.” Id. at 184. Later at the same
panel, he said, “it’s always a good theory that you talk about fertil-
ity preservation with a 14 year old, but I know I’m talking to a blank
wall.” Id. at 192. Another provider at the same panel discussed the
difficulty in helping nine-, ten-, and eleven-year-olds understand
the long-term effects of puberty blockers on their fertility. Id. at
193. “I’m definitely a little stumped,” she admitted. Id.
In one of the leaked documents, Dr. Marci Bowers—a gyne-
cological surgeon and WPATH’s President—states: “[A]cknowl-
edgement that de-transition exists to even a minor extent is consid-
ered off limits for many in our community.” Id. at 111. Bowers
agreed with this practice, continuing, “I do see talk of the [detran-
sition] phenomenon as distracting from the many challenges we
face.” Id. These recent revelations only further confirm the
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 59 of 173
unsettled nature of this field, the risks involved for Alabama’s
youth, and the need for judicial caution.
Finally, it is rational for Alabama to conclude that there are
alternatives to childhood use of cross-sex hormones and puberty
blockers. Although the suicide rate is high in the transgender com-
munity, Dr. Cass’s April 2024 study concluded that “there is no ev-
idence that gender-affirmative treatments reduce [suicidality.]” See
The Cass Review, supra n.2, at 195. The report continued that the
available evidence “suggests that these deaths are related to a range
of other complex psychosocial factors and to mental illness.” Id.
Alabama could rationally conclude that suicidality—which is a
mental-health problem—should be treated with counseling, medi-
cation, and other forms of psychotherapy.
Comparatively, none of the studies that Judge Rosenbaum’s
dissent relies on provide a solid basis for her claim that “studies
have repeatedly shown that gender-affirming hormone therapy
markedly decreases suicidality and depression among transgender
minors who want such care.” Rosenbaum Dis. Op. at 41 n.22. Start
with the Tordoff study. Judge Rosenbaum claims that puberty
blockers and “gender-affirming” hormones led to a “60% decrease
in depression” and a “73% decrease in suicidality.” Id; see Diana M.
Tordoff, et al., Mental Health Outcomes in Transgender and Nonbinary
Youths Receiving Gender-Affirming Care, 5 J. Am. Med. Ass’n Network
Open 1, (2022). But this is misleading, as almost all the participants
who did not take puberty blockers or cross-sex hormones dropped
out of the study before its conclusion, weakening any potential
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 60 of 173
conclusions. Tordoff, et al., Mental Health Outcomes, 5 J. Am. Med.
Ass’n Network Open at at 1; Tordoff, et al., Mental Health Outcomes,
Supplemental Online Content, eTable 2, eTable 3.
Next is the Green study. Judge Rosenbaum claims that this
study demonstrates a “40% decrease in depression and suicidality.”
Rosenbaum Dis. Op. at 41 n.22. It is true that the study represented
that receipt of hormone therapy was associated with lowered odds
of recent depression and the serious consideration of suicide in the
past year. Amy E. Green et al., Association of Gender-Affirming Hor-
mone Therapy With Depression, Thoughts of Suicide, and Attempted Su-
icide Among Transgender and Nonbinary Youth, 70 J. of Adolescent
Health 643, 647 (2022). But significantly, the authors also noted
that, because of the study’s cross-sectional design, “causation
[could not] be inferred.” Id. at 648.
Judge Rosenbaum next relies on the Turban study, which
she claims demonstrates a “statistically significant decrease in sui-
cidal ideation.” Rosenbaum Dis. Op. at 41 n.22; see Jack L. Turban
et al., Pubertal Suppression for Transgender Youth and Risk of Suicidal
Ideation, 145 Pediatrics 1, 5–6 (2020). This study pulled data from
the 2015 US Transgender Survey, but out of the 3,494 participants
in the study, only 89 reported that they received puberty blockers.
Id. at 3–4. The authors reported that “[t]reatment with pubertal
suppression among those who wanted it was associated with lower
odds of lifetime suicidal ideation when compared with those who
wanted pubertal suppression but did not receive it.” Id. at 5. But
near the end of their paper, the authors admit that the design of
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 61 of 173
their study “does not allow for determination of causation.” Id. at
7. Further, as detailed in a review of the study, there are good rea-
sons to question the data set used by the authors, for it “included
older respondents who, in fact, had no opportunity to obtain these
drugs and so cannot be used for comparison.” Michael Biggs, Pu-
berty Blockers and Suicidality in Adolescents Suffering from Gender Dys-
phoria, 49 Archives of Sexual Behav. 2227, 2228 (2020). The Turban
study also fails to control for preexisting psychological problems.
In order to provide true insight, the study would need to measure
“the respondent’s psychological problems before [the puberty
blockers were] prescribed or withheld.” Id. (emphasis omitted).
Without this information, “a negative association found many
years after treatment is compatible with three scenarios: puberty
blockers reduced suicidal ideation; puberty blockers had no effect
on suicidal ideation; [or] puberty blockers increased suicidal idea-
tion, albeit not enough to counteract the initial negative effect of
psychological problems on eligibility.” Id. And finally, England’s
National Institute for Health and Care Excellence excluded the
Turban study from its evidence report because the data for puberty
blockers was “not reported separately from other interventions.”
Therefore, the Turban study, as with the others already discussed,
provides no probative causal connection between suicidality and
the use of puberty blockers.
Finally, Judge Rosenbaum turns to the Allen study, which
she claims documents a “75% decrease in suicidality.” Rosenbaum
Dissenting Op at 41 n.22; see Luke Allen et al., Well-being and Sui-
cidality Among Transgender Youth after Gender-affirming Hormones, 7
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 62 of 173
Clinical Practice in Pediatric Psychology 302, 306 (2019). But like
the other studies, the Allen study’s authors could not conclude that
the hormone treatments were “causally responsible for the benefi-
cial outcomes observed,” because, in this case, the study lacked a
control group. Id. at 309. The authors also did not screen for
whether the patient was actively receiving psychotherapy, which
further weakens any inference of causation. See id. at 308.
In all, none of these studies provides real support for Judge
Rosenbaum’s discussion of the supposed benefits of cross-sex hor-
mones and puberty blockers. Nor do they undermine Cass’s four-
year independent review of the available evidence, which con-
cluded that “there is no evidence that gender-affirmative treatments
reduce [suicidality.]” See The Cass Review, supra n.2, at 195 (em-
phasis added). All of this underscores that this is an issue for the
political branches, not the judicial branch.
Ultimately, the Alabama legislature is entitled to review all
the available evidence and decide whether to circumscribe cross-
sex hormone and puberty blocking medications for the purposes
set forth in the Act. On rational-basis review, our role is not “to
judge the wisdom, fairness, or logic of [that] legislative choice[].”
Beach Commc’ns, 508 U.S. at 313. Our role is to simply ask whether
there is a “conceivable basis” for Alabama’s law. Id. at 315. Under
this lenient standard, the existing evidence overwhelmingly sug-
gests that Alabama has a rational basis for the Act. Our panel opin-
ion correctly determined that the Act likely satisfies rational-basis
scrutiny.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 63 of 173
III. CONCLUSION
Alabama enacted an entirely rational law. The Fourteenth
Amendment, as informed by text, history, tradition, and our prec-
edents, does not prevent Alabama from doing so. Instead of acting
as a “super-legislature,” Day-Brite Lighting Inc. v. Missouri, 342 U.S.
421, 423 (1952), our Court has correctly allowed Alabama to “safe-
guard[] the physical and psychological well-being” of its minors,
Globe Newspaper Co., 457 U.S. at 607. I therefore concur in the de-
cision to deny rehearing en banc.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 64 of 173
Appendix A: KathyGrace Duncan 20
1. I am over the age of 18 years and am not a party to this ac-
tion. I have actual knowledge of the following facts and if called
upon to testify to them could and would do so competently. I am
submitting this Declaration in support of Defendants’ opposition
to Plaintiffs’ Motion for a Temporary Restraining Order and Pre-
liminary Injunction.
2. Alabama’s Vulnerable Child Compassion and Protection
Act (“VCCAP”) is a necessary, potentially life-saving law that will
protect vulnerable children and their parents from the heartbreak-
ing regret, irreversible physical changes, sexual dysfunction and
emotional pain that I have experienced after undertaking medical
and surgical interventions aimed at “transitioning” me from a fe-
male to a “male.”
3. From a very young age, I was what is called today “gender
non-conforming.” I preferred male clothing, I thought I was a
“boy” and I wanted to live as one.
4. I grew up in a dysfunctional family in which my mother was
often the victim of my father’s emotional and verbal abuse. As a
result I internalized the message that “my dad would love me if I
were a boy.”
20 The following appendices are reproductions of written declarations submit-
ted by Alabama.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 65 of 173
5. Sexual abuse by a family member between the ages of 10
and 12 further convinced me that being a girl meant being unsafe
and unlovable.
6. In sixth grade, I learned about female to male transsexuals.
I believed that my distress was caused by not having the “right”
body and the only way to live a normal life was to medically tran-
sition and become a heterosexual male.
7. At age 19, I began living as a man named Keith and went to
a therapist who formally diagnosed me with gender dysphoria. I
began testosterone and a year later had a mastectomy. At the time,
I believed it was necessary so that what I saw in the mirror matched
what I felt on the inside.
8. I never viewed my condition as touching on mental health
issues, and neither did the therapist who diagnosed me. The ques-
tion of whether my self-perception and desire to transition was re-
lated to [my] mental health issues was never explored.
9. After 11 years passing as a man and living what I thought
was a relatively “happy” and stable life (which included having a
number of girlfriends), I realized that I was living a lie built upon
years of repressed pain and abuse. Hormones and surgery had not
helped me resolve underlying issues of rejection, abuse, and sexual
assault. I came to understand that my desire to live as a man was a
symptom of deeper unmet needs.
10. With the help of life coaches and a supportive community, I
returned to my female identity and began addressing the underly-
ing issues that had been hidden in my attempt to live as a man. I
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 66 of 173
experienced depression that I had repressed for years and grieved
over the irreversible changes to my body.
11. If someone had walked with me through my feelings in-
stead of affirming my desire to transition, then I would have been
able to address my issues more effectively and not spend so many
years making and recovering from a grave mistake.
12. Alabama’s VCCAP Act is necessary and essential because it
will give children and adolescents a chance to walk through their
feelings and address their underlying issues effectively without be-
ing pulled onto the affirmation conveyor belt. Hormones and sur-
gery are irreversible decisions that children and adolescents are in-
capable of making.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 67 of 173
Appendix B: Carol Frietas
1. I am over the age of 18 years and am not a party to this ac-
tion. I have actual knowledge of the following facts and if called
upon to testify to them could and would do so competently. I am
submitting this Declaration in support of Defendants’ opposition
to Plaintiffs’ Motion for a Temporary Restraining Order and Pre-
liminary Injunction.
2. Alabama’s Vulnerable Child Compassion and Protection
Act (“VCCAP”) is a necessary, potentially life-saving law that will
protect vulnerable children and their parents from the heartbreak-
ing regret, irreversible physical changes, and emotional pain that I
have experienced after undertaking medical and surgical interven-
tions aimed at “transitioning” me from a female to a “male.”
3. As a youth, I was what today is called “gender non-conform-
ing,” but I lived in a household where gender expression was
strictly aligned with cultural stereotypes. I was not allowed to wear
boys’ clothes or play boys’ sports.
4. At puberty I realized I was same-sex attracted with crushes
on girls. I became depressed and anxiety-ridden as I feared what
“being gay” might mean to how I lived my life and my family rela-
tionships. I dropped out of school.
5. At age 20, I began to meet other LGBT youth and my life
stabilized. However, I also learned that many masculine females,
like me, felt that they were “born in the wrong body” and were
transitioning, so I adopted that persona.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 68 of 173
6. I went to a gender therapist who diagnosed me with gender
dysphoria and told me that transition was the only treatment that
would alleviate my discomfort and anxiety.
7. However, at that time there were gatekeeping standards for
gender transition, which required that I first live as man for six
months, including using a male name, showing a male appearance,
and using male spaces. I had very large breasts and could not pass
for a male in male spaces, so I did not pursue testosterone at that
time. I viewed myself as a male trapped in the “wrong body,” but
my mental health otherwise was stable.
8. In 2014, I revisited the idea of transitioning, believing it
would make me feel better because I was undergoing trauma in
various forms. My grandmother who had practically raised me
died. I had suffered severe abuse and neglect in childhood, and in
retrospect believe I was experiencing symptoms of PTSD from
that. I had just become a new mother a couple of months before
my brother-in-law committed suicide.
9. I spiraled downward and wanted out. I couldn’t commit su-
icide because I was a mother, so I returned to the idea of transition,
believing it would help me feel better. By that time the require-
ments for testosterone had lessened. I went to Planned
Parenthood for testosterone and was given it right away, with no
information. I was not given any information on uterine atrophy,
vaginal atrophy, or other effects of testosterone and the staff did
not talk about any of my emotional or mental health issues.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 69 of 173
10. Four months after starting testosterone, I went to a plastic
surgeon for a mastectomy. I needed a letter from a therapist and
received one from the therapist who had affirmed me and origi-
nally recommended transition. As was true with testosterone, I
was not given any information about the procedure. Instead I had
a consultation with the surgeon, who said “this is what we are go-
ing to do,” drew on my chest, took pictures and asked me what I
wanted out of the surgery. He said “we’ll create a masculine look-
ing chest, you’ll look great.”
11. During the first four months on testosterone menstruation
stopped, my sex drive went way up, my voice deepened, and facial
and body hair came in. As I continued on testosterone, my person-
ality changed drastically and my verbal abilities declined. Testos-
terone lowered and muted my emotions and empathy, but also
gave me a lot of energy and a sense of a high. My depression and
anxiety worsened to the point that I was having such severe panic
attacks that I could not leave home. I told my doctors that I
thought the testosterone was making the anxiety worse, but they
said no.
12. I went to a psychiatrist . . . specifically to deal with the de-
pression and I was provided with an anti-depressant that really
worked. I felt mentally stable and able to address the trauma that
led me to transition.
13. Within a month of starting the anti-depressant, I realized
that I had not needed to transition. It was the biggest mistake I had
ever made. I did not detransition for a year because I couldn’t
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 70 of 173
believe that it was so easy, i.e., that anti-depressants alleviated my
depression and enabled me to think clearly and reason better. This
allowed me [to] address my internalized homophobia and child-
hood abuse through therapeutic means.
14. Meanwhile, my health began going downhill. Before going
on testosterone, I had no health problems. After being on it for
four years, I was pre-diabetic, had high cholesterol, and had a high
red blood cell count to the point that doctors were recommending
that I donate blood to reduce the volume.
15. I stopped taking testosterone and four months later my
blood work was back down to normal. I thought to myself “How
do they [doctors] not know about this?” Going off testosterone al-
lowed me to finally sleep. I felt like I never slept all the time that I
was taking testosterone. Going off testosterone also helped with
empathy and other emotions. My personal relationships, including
my relationship with my wife, were better.
16. I believe that healthcare providers did not ask me about
mental health issues because they believed that those issues were
caused by gender dysphoria and that transitioning would fix the
problem. In fact, the opposite was true.
17. I would have been spared physical, psychological, and emo-
tional losses if I had received a proper diagnosis and treatment for
PTSD and depression before undergoing years of medical and sur-
gical interventions. Alabama’s VCCAP Act is necessary and essen-
tial because it will give children and adolescents the chance to work
through and address their underlying issues such as depression or
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 71 of 173
PTSD effectively without being pulled onto the affirmation con-
veyor belt. Hormones and surgery are irreversible decisions that
children and adolescents are incapable of making.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 72 of 173
Appendix C: Corinna Cohn
My name is Corinna Cohn. I am over the age of 19, I am
qualified to give this declaration, and I have personal knowledge of
the matters set forth herein.
In or about 2nd grade, I saw a psychologist for problems re-
lated to being bullied and emotional regulation. After less than a
year, my parents chose to discontinue therapy. I continued to be
bullied and had problems forming friendships. Other boys ex-
cluded me from social activities. Later in elementary school I be-
gan to pray to be made into a girl, which I thought would allow me
to fit in better. This became a fixation for me.
In high school, I confessed to my parents that I wanted to
become a woman. They brought me to see the same psychologist
I’d had as a child, and she diagnosed me with having gender iden-
tity disorder. Upon receiving my diagnosis, my parents again chose
to discontinue my therapy. I continued to have problems socializ-
ing at school and experienced depression and anxiety on a daily ba-
sis.
At the age of 17, I gained access to the Internet. This was
prior to the popularization of the World Wide Web, but I was able
to use message boards . . . in order to find other members of what
today would be called the “trans community.” Adult transgender
women befriended me, supplied me with validation and support,
and provided information on how I could transition to become a
transgender woman.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 73 of 173
At the age of 18, I resumed my sessions with my psycholo-
gist with the goal of receiving a prescription for cross-sex hormones
and eventual sex reassignment surgery. Due to my prior relation-
ship with my psychologist, I was able to gain a letter of recommen-
dation to an endocrinologist and was prescribed estrogen. The en-
docrinologist was referred to me by transgender friends on the In-
ternet. I began living as a woman and had my legal identification
updated to reflect my chosen name.
I had sex reassignment surgery in Neenah, Wisconsin in
1994. I was only 19 years old. Securing the appointment required
letters from two therapists along with a letter from my endocrinol-
ogist. My surgeon told me I was the second-youngest patient he
had operated on. The surgery involved the removal of my testicles,
penectomy, and vaginoplasty. It was successful and without com-
plication.
After healing from my sex change surgery I thought that my
transition journey was over. I discontinued therapy, and I began
focusing on my career. I found it was easier to socialize and make
new friends with my new confidence and feelings of being my au-
thentic self. As I reached my late twenties, my friends began pair-
ing off and starting families. I discovered that it was very difficult
to find a partner who wanted to do the same with me.
Although I was in denial for several years, I eventually real-
ized that my depression and anxiety related to my gender identity
had not resolved. It was not unusual for me to spend entire week-
ends in my room crying and entertaining thoughts of suicide.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 74 of 173
In my mid-thirties I became interested in radical feminism.
I am not a feminist, nor have I ever been, but I wanted to reconcile
how feminist concepts applied to people like myself: males who try
to turn ourselves into women. One of the concepts I found pivotal
was the feminist criticism of biological essentialism, which chal-
lenges the idea that men and women are destined to fulfill rigid sex
roles. Once I understood this criticism I realized that my more ste-
reotypically feminine attitudes and behaviors did not therefore
make me a woman, but rather a feminine man. In retrospect, my
self-perception of being a woman also required that I overlook or
discount traits that are more stereotypically masculine. Although
it took time for this realization to fully sink in, a side effect was that
I stopped having bouts of depression and anxiety related to my gen-
der identity. I have not had any depressive episodes related to gen-
der identity in ten years. As a teenager I was unprepared to under-
stand the consequences of my decision to medicalize my transition
despite the rigorous controls that were in place to ensure that pa-
tients would not be harmed from gender affirming care.
...
I wish I could persuade other boys who wish to become
women that the changes they seek are only superficial. Hormones
and surgery are unable to reveal an authentic self, and anyone who
promises otherwise is, in my opinion, deliberately misleading
young people to follow a one-way track to a lifetime of medicaliza-
tion. Although some people may choose to transition, and may
even enjoy a higher quality of life, there is no reason why this
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 75 of 173
irreversible decision needs to be made in adolescence. Adults who
advocate for adolescent transition do so without understanding
what tradeoffs early transition entails, which includes the loss of
fertility, the likelihood of sexual dysfunction, and the likelihood of
surgical complication inflicted at an early age from elective proce-
dures. Unfortunately, I do understand some of these tradeoffs
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 76 of 173
WILSON, Circuit Judge, dissenting from the denial of rehearing en
banc, joined by JORDAN, Circuit Judge:
This case presents numerous questions “of exceptional im-
portance” worthy of en banc review. Fed. R. App. P. 35(a)(2). See-
ing that this case implicates the contours of substantive due pro-
cess, fundamental rights, and equal protection, it is difficult to en-
vision issues of greater importance.
I. Substantive Due Process
The divergent descriptions of the fundamental right at issue
and disagreement over whether substantive due process protects
that right demonstrate a need for rehearing en banc.
The district court relied on the Supreme Court’s decision in
Troxel v. Granville, among others, which recognized the fundamen-
tal right of parents to “make decisions concerning the care, cus-
tody, and control of their children.” 530 U.S. 57, 66 (2000) (plurality
opinion); see also Pierce v. Soc’y of the Sisters of the Holy Names of Jesus
and Mary, 268 U.S. 510, 534–35 (1925); Meyer v. Nebraska, 262 U.S.
390, 399 (1923). The district court then determined that this recog-
nized fundamental right includes the “right to treat [one’s] children
with transitioning medications subject to medically accepted stand-
ards.” Eknes-Tucker v. Marshall, 603 F. Supp. 3d 1131, 1144 (N.D. Ala.
2022). Judge Rosenbaum takes a parallel approach in her dissent
from denial of rehearing. She identifies the fundamental right at
issue as one that sits within Parham v. J.R.’s more general fundamen-
tal right. See 442 U.S. 584, 602 (1979). However, her articulation is
more specific; she describes the fundamental right at issue as the
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 77 of 173
“right to direct that [one’s] child receive well-established, evidence-
based, non-experimental medical treatment, subject to medically
accepted standards and a physician’s independent examination and
medical judgment.” Rosenbaum Dissent at 1. Meanwhile, Judge
Jordan broadly describes the fundamental right as “the right of par-
ents to obtain medically-approved treatment for their children.”
Jordan Dissent at 22. In contrast, the panel describes the funda-
mental right at issue as only “the right to treat [one’s] children with
transitioning medications subject to medically accepted standards,”
which it views as separate and distinct from the fundamental right
to “make decisions concerning the ‘upbringing’ and ‘care, custody,
and control’ of one’s children.” Eknes-Tucker v. Governor of Alabama,
80 F.4th 1205, 1224 (11th Cir. 2023). All four opinions articulate the
fundamental right at issue with varying degrees of specificity. Re-
hearing en banc would have provided us with an opportunity to
clarify the fundamental right at issue and the protections guaran-
teed by the Due Process Clause. 1
1 Incidentally, I note several inconsistencies in Judge Lagoa’s Statement. For
one, the Statement discusses the facts and introduces new factual material.
See Judge Lagoa’s Statement at 4–6, 29–31, 44, 48–49. We must respect the
district court as the finder of fact. See Gonzalez v. Governor of Georgia, 978 F.3d
1266, 1270 (11th Cir. 2020). Neither the panel nor Judge Lagoa can reevaluate
factual determinations or consider materials not before us, as the Statement
does. See also Rosenbaum Dissent at 8 n.7. Further, I struggle with Judge La-
goa’s discussion of medical findings, given her pronouncement that “[n]either
an unelected district judge nor unelected circuit judge should resolve” policy
questions informed by scientific, philosophical, and moral considerations. If
this case presents policy questions that courts are ill-suited to resolve, a
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 78 of 173
II. Equal Protection
Like Judge Rosenbaum, I am also concerned with the panel’s
equal protection analysis—particularly its quick and improper dis-
missal of Bostock and Brumby. The panel concludes that because
Bostock and Brumby involved gender stereotyping in the context of
employment discrimination, their holdings are irrelevant here. I
am not so sure.
In Brumby, we explained that “[a] person is defined as
transgender precisely because of the perception that his or her be-
havior transgresses gender stereotypes,” and accordingly held that
“discrimination against a transgender individual because of her
gender-noncomformity is sex discrimination.” Glenn v. Brumby, 663
F.3d 1312, 1316–17 (11th Cir. 2011). Our analysis drew from “foun-
dational cases” in which the Supreme Court “concluded that dis-
criminatory state action could not stand on the basis of gender ste-
reotypes.” Id. at 1319. But these cases were not limited to the em-
ployment context and included examples of gender stereotyping in
the provision of social security benefits, military benefits, educa-
tion, and child support payments. Id. at 1319–20. The same is true
of Bostock, which held that “discrimination based on . . .
transgender status necessarily entails discrimination based on sex.”
Bostock v. Clayton Cnty., 590 U.S. 644, 669 (2020). In reaching this
holding, the Supreme Court also relied on precedent describing in-
stances of discrimination more broadly. See id. at 677–78. The
statement for denial of rehearing en banc is not the place for credibility deter-
minations regarding evidence.
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 79 of 173
panel looks only to Bostock and Brumby’s employment outcome, ra-
ther than drawing from the underlying reasoning in each case to
determine when gender and sex stereotyping rises to the level of a
constitutional violation. 2 See Fowler v. Stitt, 104 F.4th 770, 790 (10th
Cir. 2024) (“Although that was the only question the Supreme
Court decided, the Court did not indicate that its logic concerning
the intertwined nature of transgender status and sex was confined
to Title VII.”).
Judge Brasher’s concurrence, in which he states that the Act
does not contain a sex classification, is also indicative of the need
for en banc review. Eknes-Tucker, 80 F.4th at 1233 (Brasher, J., con-
curring). The Act is aimed at addressing the treatment of minors
who experience “a discordance between the individual’s sex and
sense of identity.” Ala. Code § 26-26-2(16). The word “sex” is not
only, as Judge Brasher concedes, riddled throughout the Act, it is
used to separate minors who experience a “discordance” between
their birth-assigned sex and gender identity from those who do not
2 See, e.g., Price Waterhouse v. Hopkins, 490 U.S. 228, 251 (1989) (explaining that
gender stereotyping can play a role in gender-based discrimination); City of
L.A., Dep’t of Water and Power v. Manhart, 435 U.S. 702, 709–10 (1978) (stating
that employment practices which classify people based on sex often “preserve
traditional assumptions about groups rather than thoughtful scrutiny of indi-
viduals”); Stanton v. Stanton, 421 U.S. 7, 14–15 (1975) (finding that “‘old no-
tions’” of the traditional roles of men and women did not support Utah’s sex-
based classification of child support payments).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 80 of 173
experience such a “discordance.” This seems like a sex-based clas-
sification. 3
The Act as it stands now shapes the way parents of
transgender children may care for their children, while parents of
cisgender children remain unaffected. Should a parent of a child be
prevented from seeking medical care because of the sex of their
child? See Stanton, 421 U.S. at 14–15 (“A child, male or female, is
still a child.”). Reading the Act as though it does not distinguish
and classify minors will only lead to future confusion and contra-
dictory results in the interpretation of similar state statutes across
the circuit.
* * *
For these reasons, it is difficult to envision issues of greater
importance than those presented here. We should have reheard
this case en banc. Accordingly, I respectfully dissent from our re-
fusal to do so.
3 See Kadel v. Folwell, 100 F.4th 122, 146 (4th Cir. 2024) (en banc) (“[G]ender
dysphoria is so intimately related to transgender status as to be virtually indis-
tinguishable from it. The excluded treatments aim at addressing incongruity
between sex assigned at birth and gender identity, the very heart of
transgender status.”).
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 81 of 173
JORDAN, Circuit Judge, joined by ROSENBAUM and JILL PRYOR, Cir-
cuit Judges, dissenting from the denial of rehearing en banc.
Substantive due process is hard. Acknowledging the com-
plexity of the doctrine, I write to discuss what I perceive to be some
analytical flaws in the panel’s opinion.
I
In this case, the panel characterized the liberty interest in
part by asking whether there is a history of recorded uses of tran-
sitioning medications for transgender individuals (e.g., puberty
blockers and cross-sex hormone treatments) as of 1868, when the
Fourteenth Amendment was ratified. Finding no such history, the
panel concluded that there is no fundamental right for parents to
treat their children with such medications. See Eknes-Tucker v. Gov-
ernor of Alabama, 80 F.4th 1205, 1220–21, 1224 (11th Cir. 2023).
The panel’s decision necessarily means that the fundamental
right of parents to obtain medical treatment for their children ex-
tends only to procedures and medications that existed in 1868, and
not to modern advances like the polio vaccine (developed in the
1950s), cardiac surgery (first performed in 1893), organ transplants
(first successfully completed in 1954), and treatments for cancer
like radiation (first used in 1899) and chemotherapy (which started
in the 1940s). See Judge Rosenbaum Dissent at Part II.A.2. There
is admittedly some support in our cases for the panel’s approach,
see Morrissey v. United States, 871 F.3d 1260, 1269–70 (11th Cir. 2017)
(holding that a man does not have a substantive due process right
to procreate through in-vitro fertilization because that technology
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 82 of 173
was only successfully developed in the 1970s), but that analysis is
too simple and ignores many Supreme Court cases that define fun-
damental rights at a much more general level without requiring es-
tablished and precise historical pedigrees. Cf. Obergefell v. Hodges,
576 U.S. 644, 664 (2015) (“The generations that wrote and ratified
the Bill of Rights and the Fourteenth Amendment did not presume
to know the extent of freedom in all of its dimensions, and so they
entrusted to future generations a charter protecting the right of all
persons to enjoy liberty as we learn its meaning.”); Home Bldg. &
Loan Ass’n v. Blaisdell, 290 U.S. 398, 442–43 (1934) (“It is no answer
to say that this public need was not apprehended a century ago, or
to insist that what the provision of the Constitution meant to the
vision of that day it must mean to the vision of our time. If by the
statement that what the Constitution meant at the time of its adop-
tion it means today, it is intended to say that the great clauses of
the Constitution must be confined to the interpretation of the
framers, with the conditions and outlook of their time, would have
placed upon them, the statement carries its own refutation. It was
to guard against such a narrow conception that Chief Justice Mar-
shall uttered the memorable warning: ‘We must never forget, that
it is a constitution we are expounding[.]’”) (internal citations and
quotations omitted).
Some have said that in constitutional law the “[l]evel of gen-
erality is everything[.]” L.W. v. Skrmetti, 83 F.4th 460, 475 (6th Cir.
2023), cert. granted, --- S.Ct. ----, 2024 WL 3089532 (2024). Even if it
is not everything, the level of generality is very important and often
determinative. In my view, the panel asked the wrong question by
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 83 of 173
defining the asserted right in too granular a way, and as a result
reached the wrong answer. Cf. Ala. Legis. Black Caucus v. Alabama,
575 U.S. 254, 279 (2015) (“Asking the wrong question may well have
led to the wrong answer.”). In the pages that follow, I try to explain
why.
II
When it comes to challenges to legislation, the substantive
component of the Due Process Clause “protects those fundamen-
tal rights and liberties which are, objectively, deeply rooted in this
Nation’s history and tradition, . . . and implicit in the concept of
ordered liberty, such that neither liberty nor justice would exist if
they were sacrificed[.]” Washington v. Glucksberg, 521 U.S. 702, 720–
21 (1997) (citations and internal quotation marks omitted). But
substantive due process also sometimes protects against abusive ex-
ecutive action. In that context the question is whether the conduct
at issue constitutes an “abuse of power . . . which shocks the con-
science.” County of Sacramento v. Lewis, 523 U.S. 833, 846 (1998).
The panel here in part relied on the substantive due process
aspect of our decision in Bendiburg v. Dempsey, 909 F.2d 463, 468
(11th Cir. 1990), calling it the “most relevant” Eleventh Circuit
precedent dealing with “parents’ liberty interest to control the up-
bringing of their children.” Eknes-Tucker, 80 F.4th at 1223. I think
the panel incorrectly characterized Bendiburg and mistakenly
viewed it as the “most relevant” of our cases.
In Bendiburg, a father asserted a substantive due process
claim based on the involuntary insertion of a certain catheter on
USCA11 Case: 22-11707 Document: 152-3 Date Filed: 08/28/2024 Page: 84 of 173
his son by private parties allegedly acting in concert with state offi-
cials. The district court in Bendiburg characterized the substantive
due process claim as one alleging abusive executive action, and re-
jected it: “The most widely accepted view is that substantive due
process is violated by government conduct that ‘shocks the con-
science’ or when the government engages in action ‘which offends
those canons of decency and fairness which express the notions of
justice of English speaking peoples.’ The question before the court
is thus whether the evidence of record suggests state conduct that
was so shocking or egregious as to give rise to a claim for damages
under the concept of substantive due process. The court finds that
it does not.” Bendiburg v. Dempsey, 707 F. Supp. 1318, 1324 (N.D.
Ga. 1989) (citations omitted).
On appeal, the Bendiburg panel af
This text is long and has been trimmed here. Open the source document for the complete record.